Recent trends in the management of minor salivary gland carcinoma

The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional...

Full description

Saved in:
Bibliographic Details
Published inHead & neck Vol. 36; no. 3; pp. 444 - 455
Main Authors Poorten, Vincent Vander, Hunt, Jennifer, Bradley, Patrick J., Haigentz Jr, Missak, Rinaldo, Alessandra, Mendenhall, William M., Suarez, Carlos, Silver, Carl, Takes, Robert P., Ferlito, Alfio
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.03.2014
Wiley Subscription Services, Inc
Subjects
Biomarkers, Tumor - metabolism
Biopsy, Fine-Needle
carcinoma
Diagnostic Imaging
Humans
Laryngeal Neoplasms - diagnosis
Laryngeal Neoplasms - pathology
Laryngeal Neoplasms - radiotherapy
Laryngeal Neoplasms - surgery
management
minor salivary gland
Oropharyngeal Neoplasms - diagnosis
Oropharyngeal Neoplasms - pathology
Oropharyngeal Neoplasms - radiotherapy
Oropharyngeal Neoplasms - surgery
outcome
Prognosis
salivary gland neoplasms
Salivary Gland Neoplasms - diagnosis
Salivary Gland Neoplasms - pathology
Salivary Gland Neoplasms - radiotherapy
Salivary Gland Neoplasms - surgery
Salivary Glands, Minor
minor salivary gland
salivary gland neoplasms
carcinoma
management
outcome
Online AccessGet full text
ISSN1043-3074
1097-0347
1097-0347
DOI10.1002/hed.23249

Cover

Abstract The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional or punch biopsy determines the histologic type and grade. Recent advances in molecular biology have yielded diagnostic and potential therapeutic targets that may change our treatment in the future. Complete resection is the treatment of choice. Unfortunately, given the proximity of essential structures, the need to balance functional and cosmetic with oncologic consequences can interfere with an adequate “clear margin.” The neck should be treated when there is evidence of regional metastasis or when subclinical metastatic risk exceeds 15%. Surgery alone cures most low‐stage, low‐grade tumors, all other stages and grades require postoperative radiotherapy. Systemic treatment for locoregional and distant failure remains disappointing. © 2013 Wiley Periodicals, Inc. Head Neck 36: 444–455, 2014
AbstractList The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional or punch biopsy determines the histologic type and grade. Recent advances in molecular biology have yielded diagnostic and potential therapeutic targets that may change our treatment in the future. Complete resection is the treatment of choice. Unfortunately, given the proximity of essential structures, the need to balance functional and cosmetic with oncologic consequences can interfere with an adequate "clear margin." The neck should be treated when there is evidence of regional metastasis or when subclinical metastatic risk exceeds 15%. Surgery alone cures most low-stage, low-grade tumors, all other stages and grades require postoperative radiotherapy. Systemic treatment for locoregional and distant failure remains disappointing.
The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional or punch biopsy determines the histologic type and grade. Recent advances in molecular biology have yielded diagnostic and potential therapeutic targets that may change our treatment in the future. Complete resection is the treatment of choice. Unfortunately, given the proximity of essential structures, the need to balance functional and cosmetic with oncologic consequences can interfere with an adequate "clear margin." The neck should be treated when there is evidence of regional metastasis or when subclinical metastatic risk exceeds 15%. Surgery alone cures most low-stage, low-grade tumors, all other stages and grades require postoperative radiotherapy. Systemic treatment for locoregional and distant failure remains disappointing. © 2013 Wiley Periodicals, Inc. Head Neck 36: 444-455, 2014 [PUBLICATION ABSTRACT]
The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional or punch biopsy determines the histologic type and grade. Recent advances in molecular biology have yielded diagnostic and potential therapeutic targets that may change our treatment in the future. Complete resection is the treatment of choice. Unfortunately, given the proximity of essential structures, the need to balance functional and cosmetic with oncologic consequences can interfere with an adequate “clear margin.” The neck should be treated when there is evidence of regional metastasis or when subclinical metastatic risk exceeds 15%. Surgery alone cures most low‐stage, low‐grade tumors, all other stages and grades require postoperative radiotherapy. Systemic treatment for locoregional and distant failure remains disappointing. © 2013 Wiley Periodicals, Inc. Head Neck 36: 444–455, 2014
The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional or punch biopsy determines the histologic type and grade. Recent advances in molecular biology have yielded diagnostic and potential therapeutic targets that may change our treatment in the future. Complete resection is the treatment of choice. Unfortunately, given the proximity of essential structures, the need to balance functional and cosmetic with oncologic consequences can interfere with an adequate "clear margin." The neck should be treated when there is evidence of regional metastasis or when subclinical metastatic risk exceeds 15%. Surgery alone cures most low-stage, low-grade tumors, all other stages and grades require postoperative radiotherapy. Systemic treatment for locoregional and distant failure remains disappointing.The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional or punch biopsy determines the histologic type and grade. Recent advances in molecular biology have yielded diagnostic and potential therapeutic targets that may change our treatment in the future. Complete resection is the treatment of choice. Unfortunately, given the proximity of essential structures, the need to balance functional and cosmetic with oncologic consequences can interfere with an adequate "clear margin." The neck should be treated when there is evidence of regional metastasis or when subclinical metastatic risk exceeds 15%. Surgery alone cures most low-stage, low-grade tumors, all other stages and grades require postoperative radiotherapy. Systemic treatment for locoregional and distant failure remains disappointing.
The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all anatomic subsites of the head and neck. Modern imaging is essential in evaluating the location and the anatomic extent of disease. An incisional or punch biopsy determines the histologic type and grade. Recent advances in molecular biology have yielded diagnostic and potential therapeutic targets that may change our treatment in the future. Complete resection is the treatment of choice. Unfortunately, given the proximity of essential structures, the need to balance functional and cosmetic with oncologic consequences can interfere with an adequate “clear margin.” The neck should be treated when there is evidence of regional metastasis or when subclinical metastatic risk exceeds 15%. Surgery alone cures most low‐stage, low‐grade tumors, all other stages and grades require postoperative radiotherapy. Systemic treatment for locoregional and distant failure remains disappointing. © 2013 Wiley Periodicals, Inc. Head Neck 36: 444–455, 2014
Author Haigentz Jr, Missak
Rinaldo, Alessandra
Ferlito, Alfio
Bradley, Patrick J.
Takes, Robert P.
Poorten, Vincent Vander
Hunt, Jennifer
Silver, Carl
Mendenhall, William M.
Suarez, Carlos
Author_xml – sequence: 1
  givenname: Vincent Vander
  surname: Poorten
  fullname: Poorten, Vincent Vander
  email: vincent.vanderpoorten@uzleuven.be
  organization: Otorhinolaryngology-Head and Neck Surgery and Leuven Cancer Institute, Department of Oncology-Head and Neck Oncology, University Hospitals Leuven, KULeuven, Belgium
– sequence: 2
  givenname: Jennifer
  surname: Hunt
  fullname: Hunt, Jennifer
  organization: Department of Pathology and Laboratory Services, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
– sequence: 3
  givenname: Patrick J.
  surname: Bradley
  fullname: Bradley, Patrick J.
  organization: European Salivary Gland Society, Geneva, Switzerland
– sequence: 4
  givenname: Missak
  surname: Haigentz Jr
  fullname: Haigentz Jr, Missak
  organization: Division of Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York, Bronx
– sequence: 5
  givenname: Alessandra
  surname: Rinaldo
  fullname: Rinaldo, Alessandra
  organization: Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy
– sequence: 6
  givenname: William M.
  surname: Mendenhall
  fullname: Mendenhall, William M.
  organization: Department of Radiation Oncology, University of Florida, Florida, Gainesville
– sequence: 7
  givenname: Carlos
  surname: Suarez
  fullname: Suarez, Carlos
  organization: Department of Otolaryngology, Hospital Universitario Central de Asturias, Oviedo, Spain
– sequence: 8
  givenname: Carl
  surname: Silver
  fullname: Silver, Carl
  organization: Departments of Surgery and Otolaryngology-Head and Neck Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, Bronx
– sequence: 9
  givenname: Robert P.
  surname: Takes
  fullname: Takes, Robert P.
  organization: Department of Otolaryngology-Head and Neck Surgery, Radboud University Nijmegen Medical Center, The Netherlands, Nijmegen
– sequence: 10
  givenname: Alfio
  surname: Ferlito
  fullname: Ferlito, Alfio
  organization: Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23559518$$D View this record in MEDLINE/PubMed
BookMark eNp1kEFP2zAYhi3ERClw4A-gSFzgELBjO46PqCvtJAZo2jSJi-XaX8CQOMxO2frv567tDhUcLFv287z6_A7Rru88IHRM8AXBuLh8AntR0ILJHbRPsBQ5pkzsLs-M5hQLNkDDGJ8xxrRkxR4aFJRzyUm1j66-gQHfZ30Ab2PmfNY_QdZqrx-hXT50ddY634Us6sa96bDIHhvtbWZ0MOm-1YfoU62bCEfr_QD9uB5_H03zm7vJl9HVTW6YLGROZ4Lh2hYyrUpbTi0HImYgNVSSAMNG6qqkJYFaGllaYanBkhBtZwwII_QAna1yX0P3aw6xV62LBpo0DXTzqAjHuKwYrmRCT7fQ524efJpOESYryTnhIlEna2o-a8Gq1-Da9D-1KScBlyvAhC7GALUyrte963wftGsUwWpZv0r1q3_1J-N8y9iEvseu03-7BhYfg2o6_rwx8pXhYg9__hs6vKhSUMHVz9uJ4qP7B8qKifpK_wKy_6Dp
CODEN HEANEE
CitedBy_id crossref_primary_10_1177_0194599816637605
crossref_primary_10_14639_0392_100X_N2635
crossref_primary_10_1002_oto2_70030
crossref_primary_10_1007_s40136_014_0040_2
crossref_primary_10_1177_01455613251316047
crossref_primary_10_1038_s41419_021_03391_7
crossref_primary_10_1002_hed_23711
crossref_primary_10_17116_stomat202110001124
crossref_primary_10_1002_hed_26667
crossref_primary_10_1007_s11282_018_0359_3
crossref_primary_10_1111_jop_13034
crossref_primary_10_1007_s00405_014_3053_z
crossref_primary_10_7759_cureus_40112
crossref_primary_10_1016_j_oraloncology_2015_04_005
crossref_primary_10_1016_j_oraloncology_2016_12_007
crossref_primary_10_1177_00034894211069459
crossref_primary_10_1016_j_aforl_2023_06_012
crossref_primary_10_1016_j_esmoop_2022_100602
crossref_primary_10_1016_j_oraloncology_2021_105698
crossref_primary_10_4103_jomfp_jomfp_13_24
crossref_primary_10_1016_j_oraloncology_2017_07_025
crossref_primary_10_1177_0022034520965141
crossref_primary_10_1002_cncr_32208
crossref_primary_10_1002_hed_27767
crossref_primary_10_1016_j_amjoto_2021_103265
crossref_primary_10_1016_j_oor_2024_100695
crossref_primary_10_1111_1759_7714_15526
crossref_primary_10_1002_lary_31119
crossref_primary_10_1007_s00432_015_1961_y
crossref_primary_10_1111_jop_12458
crossref_primary_10_3390_jcm11154477
crossref_primary_10_1002_hed_24659
crossref_primary_10_1159_000509142
crossref_primary_10_1007_s11845_015_1298_1
crossref_primary_10_1177_107327481602300307
crossref_primary_10_1016_j_omsc_2018_100091
crossref_primary_10_1002_hed_24382
crossref_primary_10_1002_dc_25171
crossref_primary_10_1016_j_oooo_2015_10_003
crossref_primary_10_14639_0392_100X_N1729
crossref_primary_10_7759_cureus_74660
crossref_primary_10_3389_fonc_2022_1032471
crossref_primary_10_1016_j_nic_2018_01_008
crossref_primary_10_1186_s13550_020_00631_3
crossref_primary_10_1002_ijc_35167
crossref_primary_10_1007_s12285_021_00333_2
crossref_primary_10_1155_2015_827560
crossref_primary_10_1002_hed_26641
crossref_primary_10_1177_0194599817735309
crossref_primary_10_1097_MOO_0000000000000347
crossref_primary_10_1007_s00405_015_3855_7
crossref_primary_10_1016_j_canrad_2014_09_008
crossref_primary_10_1002_ohn_715
crossref_primary_10_1111_odi_15216
crossref_primary_10_1148_rg_2021200062
crossref_primary_10_1016_j_anorl_2023_11_001
crossref_primary_10_5631_jibirin_117_417
crossref_primary_10_1186_s41199_017_0024_2
crossref_primary_10_1002_hed_27143
crossref_primary_10_1007_s12285_017_0129_y
crossref_primary_10_1016_j_ijom_2020_07_034
crossref_primary_10_1007_s12285_015_0016_3
crossref_primary_10_1177_0194599820938323
crossref_primary_10_18632_oncotarget_13952
crossref_primary_10_3390_cancers15153895
crossref_primary_10_1002_dc_24473
crossref_primary_10_1016_j_rpor_2018_05_004
crossref_primary_10_1177_0194599815607449
crossref_primary_10_1016_j_otc_2021_02_011
Cites_doi 10.1016/j.oraloncology.2006.11.009
10.1002/1097-0142(197008)26:2<368::AID-CNCR2820260219>3.0.CO;2-K
10.1016/j.oraloncology.2008.10.010
10.1097/00020840-200404000-00013
10.1016/0030-4220(88)90240-X
10.1016/S0167-8140(99)00084-5
10.1177/000348949009901215
10.1001/archotol.1985.00800120058006
10.1097/00000478-200107000-00001
10.1001/archoto.2008.525
10.1038/modpathol.2011.42
10.1177/000348949009901015
10.1016/0924-4212(96)84897-3
10.1097/01.mlg.0000216900.03188.48
10.1097/00005537-200407000-00012
10.1002/hed.20651
10.1002/hed.21706
10.1158/1078-0432.CCR-10-2992
10.1016/j.radonc.2010.03.006
10.1002/hed.20274
10.1016/j.oraloncology.2008.07.010
10.1200/JCO.2005.05.3025
10.1002/hed.2890080309
10.1016/j.otohns.2010.02.033
10.1002/hed.21312
10.1016/S0196-0709(99)90028-5
10.1017/S0022215100118535
10.1200/JCO.2005.06.125
10.1002/(SICI)1097-0347(199905)21:3<255::AID-HED11>3.0.CO;2-2
10.1002/(SICI)1097-0347(199908)21:5<402::AID-HED4>3.0.CO;2-Z
10.1016/j.yexmp.2011.10.011
10.1016/S1040-8428(02)00005-7
10.1007/s00405-011-1645-4
10.1002/j.1930-2398.1988.tb00006.x
10.1002/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y
10.1177/000348949009901115
10.1097/00000421-199302000-00002
10.1016/j.oraloncology.2005.12.026
10.1016/S0002-9610(05)80081-9
10.1002/cncr.23771
10.1007/s00405-008-0882-7
10.1016/j.bjoms.2010.09.013
10.1186/1758-3284-3-31
10.1002/hed.10400
10.1002/1097-0142(19901101)66:9<2031::AID-CNCR2820660931>3.0.CO;2-7
10.1590/S1516-31802000000300004
10.1200/JCO.2005.04.192
10.1016/j.ijrobp.2006.06.050
10.1002/(SICI)1097-0347(199908)21:5<414::AID-HED6>3.0.CO;2-M
10.1016/j.otohns.2005.12.012
10.1016/j.anl.2010.02.001
10.1016/S0964-1955(97)00026-2
10.1046/j.1365-2273.1997.00041.x
10.1016/0360-3016(86)90032-5
10.1016/j.oraloncology.2005.06.024
10.1148/radiol.12111248
10.1016/j.oraloncology.2007.08.018
10.1002/1097-0142(197807)42:1<265::AID-CNCR2820420141>3.0.CO;2-Z
10.2500/105065899782102872
10.1016/0196-0709(89)90004-5
10.1177/000348940111000308
10.1016/j.amjoto.2011.08.001
10.1002/lary.20501
10.1016/0360-3016(90)90304-3
10.1002/1097-0142(19940515)73:10<2563::AID-CNCR2820731018>3.0.CO;2-X
10.1016/j.joms.2010.04.003
10.1016/j.oraloncology.2006.04.008
10.1080/02841860500543208
10.1186/1748-717X-6-149
10.1002/hed.2880170605
10.1002/cncr.25852
10.3109/00016488709107802
10.1001/archotol.1997.01900060057010
10.1002/ssu.2980110309
10.1016/S1470-2045(10)70245-X
10.1016/0360-3016(86)90411-6
10.1097/00005537-199704000-00019
10.1016/j.ijrobp.2007.04.079
10.1002/hed.21831
10.1002/cncr.11630
10.1177/000348949910800512
10.1097/00020840-199904000-00007
10.1007/s12663-011-0185-1
10.1016/j.ijrobp.2004.03.018
10.1111/j.1365-2559.2008.03159.x
10.1016/0002-9610(78)90262-3
10.1016/j.tripleo.2007.09.002
10.1016/S0360-3016(96)80005-8
10.1016/0046-8177(94)90014-0
10.1002/hed.20924
10.1093/oxfordjournals.annonc.a010684
10.1016/0360-3016(93)90233-L
10.1158/1078-0432.CCR-03-0253
10.1002/1097-0142(197712)40:6<2882::AID-CNCR2820400618>3.0.CO;2-I
10.2334/josnusd.51.509
10.1016/j.joms.2005.06.017
10.1002/1097-0142(20000915)89:6<1195::AID-CNCR2>3.0.CO;2-J
10.1002/hed.20094
10.1007/s12105-009-0102-9
10.1002/cncr.27408
10.1002/hed.2890090204
10.1002/(SICI)1097-0347(199907)21:4<297::AID-HED2>3.0.CO;2-R
10.1002/hed.20614
10.1093/ajcp/81.6.696
10.1002/cncr.21116
10.1111/j.1600-0714.1999.tb02036.x
10.1016/S0167-8140(00)00273-5
10.1016/j.ijom.2011.02.010
10.1038/sj.bjc.6603655
10.1097/MOO.0b013e3282f70441
10.1007/s12149-008-0162-z
10.1002/1097-0142(19920415)69:8<2021::AID-CNCR2820690803>3.0.CO;2-7
10.1016/0002-9610(91)90142-Z
10.1016/S1368-8375(03)00097-6
10.1080/00016489850182387
10.1016/S0002-9610(05)80721-4
10.1080/02841860600801316
10.1016/0360-3016(88)90302-1
10.1001/archotol.132.7.767
10.1097/01.mlg.0000243200.35033.2b
10.1002/cncr.26697
10.1002/1097-0142(19920715)70:2<379::AID-CNCR2820700202>3.0.CO;2-C
10.1002/hed.21988
10.1002/dc.22805
10.1016/j.bjoms.2004.01.012
10.1001/archoto.2009.70
10.1177/019459988509300309
10.1016/S0278-2391(96)90119-6
10.1002/cncr.21158
10.1136/jcp.45.9.834
10.1002/(SICI)1097-0142(19990715)86:2<207::AID-CNCR4>3.0.CO;2-Q
10.1097/00005537-200109000-00009
10.2310/7070.2003.11438
10.1016/j.anl.2005.11.005
10.1111/j.1749-4486.2009.02036.x
10.1002/hed.20729
10.1002/1097-0142(197301)31:1<117::AID-CNCR2820310116>3.0.CO;2-7
10.1002/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO;2-E
10.1016/j.joms.2010.10.010
10.1002/hed.21641
10.1016/S0901-5027(98)80307-X
10.1016/j.cancergencyto.2004.09.007
10.1016/j.clon.2008.12.009
10.1200/JCO.2007.11.8612
10.1002/1097-0142(19920601)69:11<2779::AID-CNCR2820691125>3.0.CO;2-N
10.1148/radiol.2493072045
10.1002/hed.10358
10.4161/cbt.8.10.8117
10.1016/j.oraloncology.2011.09.005
10.1001/archoto.2010.213
10.1002/hed.10193
10.1016/S0901-5027(97)80011-2
10.1148/radiology.151.2.6324280
10.1016/j.tripleo.2008.04.015
10.1002/hed.2890090604
10.1016/j.ejrad.2012.04.009
10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C
10.1007/s10006-010-0217-x
10.1017/S0022215100134681
10.1054/ijom.2002.0223
10.1258/0022215021910078
10.1016/j.oraloncology.2011.12.005
10.1016/j.oraloncology.2004.01.017
10.1200/JCO.2005.01.6055
10.1002/hed.2890080312
10.1002/hed.21980
10.1016/j.tripleo.2011.07.038
10.1288/00005537-199511000-00003
10.1002/(SICI)1097-0347(199812)20:8<699::AID-HED7>3.0.CO;2-P
10.1177/019459989411100412
10.1016/j.ijrobp.2009.01.021
10.1148/radiology.192.1.8208973
10.1046/j.1365-2273.1998.00088.x
10.1016/j.joms.2009.09.065
10.1016/S1368-8375(00)00083-X
10.1002/(SICI)1096-9896(199703)181:3<323::AID-PATH780>3.0.CO;2-K
ContentType Journal Article
Copyright Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company
Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company.
Copyright_xml – notice: Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company
– notice: Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
DOI 10.1002/hed.23249
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1097-0347
EndPage 455
ExternalDocumentID 3221300521
23559518
10_1002_hed_23249
HED23249
ark_67375_WNG_5CPZ342G_M
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADZMN
AEIGN
AEIMD
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGYGG
AHBTC
AHMBA
AIACR
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DUUFO
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
0R~
AAHHS
ACCFJ
ADZOD
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
RWI
WRC
WUP
WWO
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
ID FETCH-LOGICAL-c4929-3b740fd29fd28ad53d5e17be9ae891e40c9a86361ef9c96d7d3c0911adb4e1413
IEDL.DBID DR2
ISSN 1043-3074
1097-0347
IngestDate Fri Jul 11 01:13:12 EDT 2025
Sun Jul 13 04:48:36 EDT 2025
Mon Jul 21 06:05:32 EDT 2025
Thu Apr 24 23:07:11 EDT 2025
Tue Jul 01 03:27:47 EDT 2025
Wed Jan 22 16:40:56 EST 2025
Sun Sep 21 06:19:42 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords minor salivary gland
salivary gland neoplasms
carcinoma
management
outcome
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4929-3b740fd29fd28ad53d5e17be9ae891e40c9a86361ef9c96d7d3c0911adb4e1413
Notes ark:/67375/WNG-5CPZ342G-M
istex:B6D7D01D637D6A7C9BBB57E9EEB73FA287D9AEF6
ArticleID:HED23249
This paper was written by members of the International Head and Neck Scientific Group.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink http://hdl.handle.net/10651/27284
PMID 23559518
PQID 1498955157
PQPubID 996355
PageCount 12
ParticipantIDs proquest_miscellaneous_1500684089
proquest_journals_1498955157
pubmed_primary_23559518
crossref_citationtrail_10_1002_hed_23249
crossref_primary_10_1002_hed_23249
wiley_primary_10_1002_hed_23249_HED23249
istex_primary_ark_67375_WNG_5CPZ342G_M
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2014
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 03
  year: 2014
  text: March 2014
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Houston
PublicationTitle Head & neck
PublicationTitleAlternate Head Neck
PublicationYear 2014
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Jenkins DW, Spaulding CA, Constable WC, Cantrell RW. Minor salivary gland tumors: the role of radiotherapy. Am J Otolaryngol 1989;10:250-256.
Batsakis JG. Staging of salivary gland neoplasms: role of histopathologic and molecular factors. Am J Surg 1994;168:386-390.
Buchholz TA, Laramore GE, Griffin BR, Koh WJ, Griffin TW. The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer 1992;69:2779-2788.
McHugh CH, Roberts DB, El-Naggar AK, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer 2012;118:3928-3936.
Carrillo JF, Maldonado F, Carrillo LC, et al. Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx. Head Neck 2011;33:1406-1412.
Jones AS, Beasley NJ, Houghton DJ, Helliwell TR, Husband DJ. Tumors of the minor salivary glands. Clin Otolaryngol Allied Sci 1998;23:27-33.
Suárez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004;26:136-144.
Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer 1978;42:265-282.
Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck 1999;21:297-309.
Alavi S, Namazie A, Calcaterra TC, Blackwell KE. Glandular carcinoma of the larynx: the UCLA experience. Ann Otol Rhinol Laryngol 1999;108:485-489.
Ganly I, Patel SG, Coleman M, Ghossein R, Carlson D, Shah JP. Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg 2006;132:767-770.
Calis AB, Coskun BU, Seven H, Sayin I, Basak T. Laryngeal mucoepidermoid carcinoma: report of two cases. Auris Nasus Larynx 2006;33:211-214.
Mucke T, Tannapfel A, Kesting MR, et al. Adenoid cystic carcinomas of minor salivary glands. Auris Nasus Larynx 2010;37:615-620.
Li Q, Zhang XR, Liu XK, et al. Long-term treatment outcome of minor salivary gland carcinoma of the hard palate. Oral Oncol 2012;48:456-462.
Pantvaidya GH, Vaidya AD, Metgudmath R, Kane SV, D'Cruz AK. Minor salivary gland tumors of the sinonasal region: results of a retrospective analysis with review of literature. Head Neck 2012 Jan 31 [Epub ahead of print].
Douglas JG, Lee S, Laramore GE, Austin-Seymour M, Koh W, Griffin TW. Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors. Head Neck 1999;21:255-263.
Batsakis JG, Luna MA. Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol 1990;99:835-838.
Sadeghi A, Tran LM, Mark R, Sidrys J, Parker RG. Minor salivary gland tumors of the head and neck: treatment strategies and prognosis. Am J Clin Oncol 1993;16:3-8.
Kokemueller H, Brueggemann N, Swennen G, Eckardt A. Mucoepidermoid carcinoma of the salivary glands-clinical review of 42 cases. Oral Oncol 2005;41:3-10.
Lamarre ED, Batra PS, Lorenz RR, et al. Role of positron emission tomography in management of sinonasal neoplasms-a single institution's experience. Am J Otolaryngol 2012;33:289-295.
Spiro RH, Thaler HT, Hicks WF, Kher UA, Huvos AH, Strong EW. The importance of clinical staging of minor salivary gland carcinoma. Am J Surg 1991;162:330-336.
Ross PJ, Teoh EM, A'Hern RP, et al. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma. Clin Oncol (R Coll Radiol) 2009;21:311-314.
Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol 2009;3:69-77.
Terhaard CH, van der Schroeff MP, van Schie K, et al. The prognostic role of comorbidity in salivary gland carcinoma. Cancer 2008;113:1572-1579.
Ma DQ, Yu GY. Tumors of the minor salivary glands. A clinicopathologic study of 243 cases. Acta Otolaryngol 1987;103:325-331.
Jansisyanont P, Blanchaert RH, Ord RA. Intraoral minor salivary gland neoplasm: a single institution experience of 80 cases. Int J Oral Maxillofac Surg 2002;31:257-261.
Copelli C, Bianchi B, Ferrari S, Ferri A, Sesenna E. Malignant tumors of intraoral minor salivary glands. Oral Oncol 2008;44:658-663.
Healey WV, Perzin KH, Smith L. Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical-pathologic correlation, and results of treatment. Cancer 1970;26:368-388.
DeAngelis AF, Tsui A, Wiesenfeld D, Chandu A. Outcomes of patients with adenoid cystic carcinoma of the minor salivary glands. Int J Oral Maxillofac Surg 2011;40:710-714.
Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008;53:567-577.
Chen AM, Garcia J, Granchi P, Bucci MK, Lee NY. Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy. Clin Otolaryngol 2009;34:539-545.
Abu El-Naaj I, Leiser Y, Wolff A, Peled M. Polymorphous low grade adenocarcinoma: case series and review of surgical management. J Oral Maxillofac Surg 2011;69:1967-1972.
Persson F, Fehr A, Sundelin K, Schulte B, Loning T, Stenman G. Studies of genomic imbalances and the MYB-NFIB gene fusion in polymorphous low-grade adenocarcinoma of the head and neck. Int J Oncol 2012;40:80-84.
Hellquist HB, Sundelin K, Di BA, Tytor M, Manzotti M, Viale G. Tumor growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 1997;181:323-329.
Rugo HS, Herbst RS, Liu G, et al. Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results. J Clin Oncol 2005;23:5474-5483.
Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 2006;24:2673-2678.
Ciccolallo L, Licitra L, Cantú G, Gatta G. Survival from salivary glands adenoid cystic carcinoma in European populations. Oral Oncol 2009;45:669-674.
Lopes MA, da Cruz Perez DE, de Abreu Alves F, de Almeida OP, Kowalski LP. Clinicopathologic and immunohistochemical study of intraoral mucoepidermoid carcinoma. Otolaryngol Head Neck Surg 2006;134:622-626.
Netto JN, Miranda AM, da Silveira HM, dos Santos TC, Pires FR. Fine-needle aspiration biopsy as an auxiliary diagnostic tool on intraoral minor salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:242-245.
Pfeffer MR, Talmi Y, Catane R, Symon Z, Yosepovitch A, Levitt M. A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol 2007;43:33-36.
van der Wal JE, Snow GB, van der Waal I. Intraoral adenoid cystic carcinoma. The presence of perineural spread in relation to site, size, local extension, and metastatic spread in 22 cases. Cancer 1990;66:2031-2033.
Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, Peters LJ. Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer 1994;73:2563-2569.
Fujita G, Sato S, Kishino M, et al. Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. Mod Pathol 2011;24:885-891.
Keyes JWJr, Harkness BA, Greven KM, Williams DW III, Watson NE Jr, McGuirt WF. Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994;192:99-102.
Pinto PX, Coleman N. Regional metastasis in polymorphous low grade adenocarcinoma. Report of a case. Int J Oral Maxillofac Surg 1997;26:447-449.
Naficy S, Disher MJ, Esclamado RM. Adenoid cystic carcinoma of the paranasal sinuses. Am J Rhinol 1999;13:311-314.
Locati LD, Bossi P, Perrone F, et al. Cetuximab in recurrent and/or metastatic salivary gland carcinomas: a phase II study. Oral Oncol 2009;45:574-578.
Omlie JE, Koutlas IG. Acinic cell carcinoma of minor salivary glands: a clinicopathologic study of 21 cases. J Oral Maxillofac Surg 2010;68:2053-2057.
Hotte SJ, Winquist EW, Lamont E, et al. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 2005;23:585-590.
Cho KJ, Lee SS, Lee YS. Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 1999;21:414-419.
Simpson JR, Thawley SE, Matsuba HM. Adenoid cystic salivary gland carcinoma: treatment with irradiation and surgery. Radiology 1984;151:509-512.
Tanvetyanon T, Qin D, Padhya T, et al. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Arch Otolaryngol Head Neck Surg 2009;135:687-692.
Rosenberg L, Weissler M, Hayes DN, et al. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies. Head Neck 2012;34:872-876.
Zang G, Miao L, Mu Y, et al. Adenoviral mediated transduction of adenoid cystic carcinoma by human TRAIL gene driven with hTERT tumor specific promoter induces apoptosis. Cancer Biol Ther 2009;8:966-972.
Terhaard CH, Lubsen H, Rasch CR, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 2005;61:103-111.
Matsuzaki H, Hara M, Yanagi Y, et al. Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-Hodgkin lymphoma in oral and maxillofacial regions. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:126-133.
Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck 2007;29:907-912.
Melnick M, Sedghizadeh PP, Allen CM, Jaskoll T. Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Exp Mol Pathol 2011;92:118-125.
Eapen LJ, Gerig
2010; 14
2011; 117
1993; 27
2000; 89
1987; 103
2006; 33
2004; 26
2008; 106
2008; 105
2008; 30
1998; 82
1978; 136
2005; 61
2009; 119
1992; 51
1984; 151
1986; 8
2006; 24
1986; 9
1984; 54
2005; 103
2005; 104
2001; 59
2008; 22
1999; 52
1985; 93
2011; 69
2008; 113
1992; 45
1998; 12
1994; 73
1970; 26
2007; 69
2003; 45
2010; 32
2004; 42
2010; 37
1973; 31
1997; 22
1999; 28
1997; 26
1986; 12
2000; 118
1988; 15
1988; 10
1998; 537
1996
2008; 249
1999; 21
2003; 39
1999; 20
2007; 96
2008; 53
1997; 181
2006; 116
2011; 4
2011; 3
2012; 34
2011; 6
2012; 33
2001; 25
2003; 32
2011; 7
1999; 108
1999
1994; 168
2011; 268
1991; 162
2006; 42
2012; 113
2006; 45
1997; 33
1978; 42
2011; 92
1996; 83
2003; 25
2001; 37
1996; 110
2008; 44
2012; 48
2012; 118
2012; 40
2009; 45
2001; 91
1990; 99
1992; 164
1987; 9
1990; 18
2010; 143
1994; 25
2006; 132
2011; 10
2002; 116
1999; 86
2011; 12
2011; 17
1996; 35
2005; 27
2006; 134
2005; 23
2003; 98
2005; 25
2007; 29
2009; 51
1997; 107
2006; 64
2010; 68
2006; 66
1999; 13
2011; 24
1996; 25
2007; 25
1996; 7
1998; 27
2012; 81
2010; 76
2012; 263
1994; 111
1984; 81
2009; 21
1994; 192
1995; 17
2012
2002; 31
2005; 159
2008; 16
2011; 40
1995; 11
2013; 41
2009
1977; 40
2005; 41
1992; 106
2011; 33
2009; 135
2005
1999; 7
1998; 20
1996; 54
1998; 23
2004; 10
2009; 34
2001; 111
2001; 110
1992; 70
1990; 66
2004; 114
1993; 16
2009; 31
1989; 10
2010; 136
2004; 12
1997; 123
1988; 66
2009; 266
1995; 105
2009; 8
1992; 69
2009; 3
2007; 43
2011; 49
2010; 95
1985; 111
Bj⊘rndal K (e_1_2_3_32_1) 2012; 48
e_1_2_3_73_1
e_1_2_3_50_1
e_1_2_3_92_1
e_1_2_3_182_1
e_1_2_3_163_1
e_1_2_3_140_1
e_1_2_3_137_1
e_1_2_3_114_1
e_1_2_3_16_1
e_1_2_3_39_1
e_1_2_3_133_1
e_1_2_3_4_1
e_1_2_3_12_1
e_1_2_3_35_1
e_1_2_3_58_1
e_1_2_3_175_1
e_1_2_3_8_1
e_1_2_3_156_1
e_1_2_3_31_1
e_1_2_3_77_1
e_1_2_3_179_1
Barnes L (e_1_2_3_6_1) 2005
e_1_2_3_54_1
e_1_2_3_96_1
e_1_2_3_118_1
e_1_2_3_62_1
e_1_2_3_81_1
e_1_2_3_170_1
e_1_2_3_151_1
Eisele DW (e_1_2_3_46_1) 1999
e_1_2_3_174_1
e_1_2_3_102_1
e_1_2_3_148_1
e_1_2_3_125_1
e_1_2_3_144_1
e_1_2_3_121_1
e_1_2_3_24_1
e_1_2_3_186_1
e_1_2_3_47_1
Persson F (e_1_2_3_71_1) 2012; 40
e_1_2_3_89_1
e_1_2_3_167_1
e_1_2_3_20_1
e_1_2_3_66_1
e_1_2_3_106_1
e_1_2_3_43_1
e_1_2_3_85_1
e_1_2_3_129_1
e_1_2_3_72_1
e_1_2_3_95_1
e_1_2_3_91_1
e_1_2_3_160_1
e_1_2_3_183_1
e_1_2_3_141_1
Spiro RH (e_1_2_3_5_1) 1998; 12
e_1_2_3_115_1
e_1_2_3_138_1
e_1_2_3_111_1
e_1_2_3_134_1
e_1_2_3_38_1
e_1_2_3_19_1
e_1_2_3_57_1
e_1_2_3_153_1
e_1_2_3_34_1
e_1_2_3_176_1
e_1_2_3_7_1
e_1_2_3_15_1
e_1_2_3_30_1
e_1_2_3_53_1
e_1_2_3_76_1
e_1_2_3_99_1
e_1_2_3_119_1
e_1_2_3_157_1
e_1_2_3_11_1
e_1_2_3_61_1
e_1_2_3_84_1
Wang CC (e_1_2_3_178_1) 1996; 25
e_1_2_3_80_1
e_1_2_3_171_1
Albeck H (e_1_2_3_2_1) 1992; 51
e_1_2_3_152_1
e_1_2_3_103_1
e_1_2_3_126_1
e_1_2_3_149_1
e_1_2_3_27_1
e_1_2_3_122_1
e_1_2_3_145_1
e_1_2_3_23_1
e_1_2_3_164_1
e_1_2_3_187_1
Ochel HJ (e_1_2_3_110_1) 2005; 25
e_1_2_3_42_1
e_1_2_3_65_1
e_1_2_3_88_1
e_1_2_3_107_1
e_1_2_3_168_1
e_1_2_3_94_1
e_1_2_3_180_1
e_1_2_3_90_1
e_1_2_3_161_1
e_1_2_3_184_1
e_1_2_3_116_1
e_1_2_3_135_1
e_1_2_3_112_1
e_1_2_3_18_1
e_1_2_3_131_1
e_1_2_3_56_1
e_1_2_3_154_1
e_1_2_3_14_1
e_1_2_3_37_1
e_1_2_3_79_1
e_1_2_3_177_1
e_1_2_3_52_1
e_1_2_3_98_1
e_1_2_3_10_1
e_1_2_3_33_1
e_1_2_3_75_1
e_1_2_3_139_1
e_1_2_3_83_1
e_1_2_3_60_1
e_1_2_3_172_1
e_1_2_3_130_1
Schwarz S (e_1_2_3_69_1) 2011; 4
e_1_2_3_127_1
Sobin LH (e_1_2_3_28_1) 2009
e_1_2_3_104_1
e_1_2_3_146_1
Ellis GL (e_1_2_3_3_1) 1996
e_1_2_3_49_1
e_1_2_3_123_1
e_1_2_3_100_1
e_1_2_3_142_1
e_1_2_3_45_1
e_1_2_3_165_1
e_1_2_3_26_1
e_1_2_3_68_1
e_1_2_3_188_1
e_1_2_3_41_1
e_1_2_3_87_1
e_1_2_3_169_1
e_1_2_3_22_1
e_1_2_3_64_1
e_1_2_3_108_1
e_1_2_3_51_1
e_1_2_3_70_1
e_1_2_3_93_1
e_1_2_3_181_1
e_1_2_3_162_1
e_1_2_3_185_1
e_1_2_3_113_1
e_1_2_3_136_1
e_1_2_3_17_1
e_1_2_3_132_1
e_1_2_3_9_1
e_1_2_3_13_1
e_1_2_3_59_1
e_1_2_3_78_1
e_1_2_3_155_1
e_1_2_3_36_1
e_1_2_3_55_1
e_1_2_3_74_1
e_1_2_3_97_1
e_1_2_3_117_1
e_1_2_3_159_1
e_1_2_3_40_1
e_1_2_3_82_1
e_1_2_3_173_1
e_1_2_3_150_1
e_1_2_3_105_1
e_1_2_3_124_1
e_1_2_3_147_1
e_1_2_3_29_1
e_1_2_3_101_1
e_1_2_3_120_1
e_1_2_3_143_1
e_1_2_3_25_1
e_1_2_3_48_1
e_1_2_3_67_1
e_1_2_3_166_1
Debaere D (e_1_2_3_158_1) 2011; 7
e_1_2_3_21_1
e_1_2_3_44_1
e_1_2_3_63_1
e_1_2_3_86_1
e_1_2_3_109_1
e_1_2_3_128_1
References_xml – reference: Netto JN, Miranda AM, da Silveira HM, dos Santos TC, Pires FR. Fine-needle aspiration biopsy as an auxiliary diagnostic tool on intraoral minor salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:242-245.
– reference: Costa TP, de Araujo CE, Filipe J, Pereira AM. First-bite syndrome in oncologic patients. Eur Arch Otorhinolaryngol 2011;268:1241-1244.
– reference: Faivre S, Raymond E, Casiraghi O, Temam S, Berthaud P. Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. J Clin Oncol 2005;23:6271-6273.
– reference: Rugo HS, Herbst RS, Liu G, et al. Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results. J Clin Oncol 2005;23:5474-5483.
– reference: Cardoso WP, Denardin OV, Rapoport A, Araújo VC, Carvalho MB. Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands. Sao Paulo Med J 2000;118:69-74.
– reference: Stenner M, Klussmann JP. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. Eur Arch Otorhinolaryngol 2009;266:333-341.
– reference: Seifert G, Sobin LH. The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition. Cancer 1992;70:379-385.
– reference: Konno A, Ishikawa K, Numata T, Nagata H, Terada N, Okamoto Y. Analysis of factors affecting long-term treatment results of adenoid cystic carcinoma of the nose and paranasal sinuses. Acta Otolaryngol Suppl 1998;537:67-74.
– reference: Pires FR, Pringle GA, de Almeida OP, Chen SY. Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases. Oral Oncol 2007;43:463-470.
– reference: Paleri V, Robinson M, Bradley P. Polymorphous low-grade adenocarcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2008;16:163-169.
– reference: Xie X, Nordgard S, Halvorsen TB, Franzen G, Boysen M. Prognostic significance of nucleolar organizer regions in adenoid cystic carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg 1997;123:615-620.
– reference: Chou C, Zhu G, Luo M, Xue G. Carcinoma of the minor salivary glands: results of surgery and combined therapy. J Oral Maxillofac Surg 1996;54:448-453.
– reference: Douglas JG, Lee S, Laramore GE, Austin-Seymour M, Koh W, Griffin TW. Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors. Head Neck 1999;21:255-263.
– reference: Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Management of minor salivary gland carcinomas. Int J Radiat Oncol Biol Phys 1996;35:443-454.
– reference: Frankenthaler RA, El-Naggar AK, Ordonez NG, Miller TS, Batsakis JG. High correlation with survival of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of the parotid gland. Otolaryngol Head Neck Surg 1994;111:460-466.
– reference: Nguyen LH, Black MJ, Hier M, Chauvin P, Rochon L. HER2/neu and Ki-67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands. J Otolaryngol 2003;32:328-331.
– reference: Lopes MA, da Cruz Perez DE, de Abreu Alves F, de Almeida OP, Kowalski LP. Clinicopathologic and immunohistochemical study of intraoral mucoepidermoid carcinoma. Otolaryngol Head Neck Surg 2006;134:622-626.
– reference: Douglas JG, Goodkin R, Laramore GE. Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy. Head Neck 2008;30:492-496.
– reference: O'Brien CJ, Soong SJ, Herrera GA, Urist MM, Maddox WA. Malignant salivary tumors: analysis of prognostic factors and survival. Head Neck 1986;9:82-92.
– reference: Jenkins DW, Spaulding CA, Constable WC, Cantrell RW. Minor salivary gland tumors: the role of radiotherapy. Am J Otolaryngol 1989;10:250-256.
– reference: Horiuchi C, Tsukuda M, Taguchi T, Ishiguro Y, Okudera K, Inoue T. Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas. Ann Nucl Med 2008;22:693-698.
– reference: Kruse AL, Gratz KW, Obwegeser JA, Lubbers HT. Malignant minor salivary gland tumors: a retrospective study of 27 cases. Oral Maxillofac Surg 2010;14:203-209.
– reference: Lee N, Millender LE, Larson DA, et al. Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull. Head Neck 2003;25:210-216.
– reference: Krull A, Schwarz R, Engenhart R, et al. European results in neutron therapy of malignant salivary gland tumors. Bull Cancer Radiother 1996;83 (Suppl 1):s125-s129.
– reference: Spiro RH, Thaler HT, Hicks WF, Kher UA, Huvos AH, Strong EW. The importance of clinical staging of minor salivary gland carcinoma. Am J Surg 1991;162:330-336.
– reference: Chen AM, Bucci MK, Quivey JM, Garcia J, Eisele DW, Fu KK. Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys 2006;66:1044-1050.
– reference: Yabuuchi H, Matsuo Y, Kamitani T, et al. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? Radiology 2008;249:909-916.
– reference: Schramm VL Jr., Imola MJ. Management of nasopharyngeal salivary gland malignancy. Laryngoscope 2001;111:1533-1544.
– reference: Tanvetyanon T, Qin D, Padhya T, et al. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Arch Otolaryngol Head Neck Surg 2009;135:687-692.
– reference: Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D. Management of adenoid cystic carcinoma of minor salivary glands. J Oral Maxillofac Surg 2006;64:1114-1120.
– reference: van der Wal JE, Snow GB, van der Waal I. Intraoral adenoid cystic carcinoma. The presence of perineural spread in relation to site, size, local extension, and metastatic spread in 22 cases. Cancer 1990;66:2031-2033.
– reference: Silverman DA, Carlson TP, Khuntia D, Bergstrom RT, Saxton J, Esclamado RM. Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck. Laryngoscope 2004;114:1194-1199.
– reference: Pinto PX, Coleman N. Regional metastasis in polymorphous low grade adenocarcinoma. Report of a case. Int J Oral Maxillofac Surg 1997;26:447-449.
– reference: Batsakis JG, Luna MA, El-Naggar AK. Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas. Ann Otol Rhinol Laryngol 1990;99:929-933.
– reference: Huber PE, Debus J, Latz D, et al. Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol 2001;59:161-167.
– reference: Jansisyanont P, Blanchaert RH, Ord RA. Intraoral minor salivary gland neoplasm: a single institution experience of 80 cases. Int J Oral Maxillofac Surg 2002;31:257-261.
– reference: Omlie JE, Koutlas IG. Acinic cell carcinoma of minor salivary glands: a clinicopathologic study of 21 cases. J Oral Maxillofac Surg 2010;68:2053-2057.
– reference: Calis AB, Coskun BU, Seven H, Sayin I, Basak T. Laryngeal mucoepidermoid carcinoma: report of two cases. Auris Nasus Larynx 2006;33:211-214.
– reference: Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, Peters LJ. Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer 1994;73:2563-2569.
– reference: Haddad R, Colevas AD, Krane JF, et al. Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study. Oral Oncol 2003;39:724-727.
– reference: Pogodzinski MS, Sabri AN, Lewis JE, Olsen KD. Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope 2006;116:2145-2149.
– reference: Galer C, Santillan AA, Chelius D, et al. Minor salivary gland malignancies in the pediatric population. Head Neck 2012;34:1648-1651.
– reference: Ciccolallo L, Licitra L, Cantú G, Gatta G. Survival from salivary glands adenoid cystic carcinoma in European populations. Oral Oncol 2009;45:669-674.
– reference: Terhaard CH, Lubsen H, Rasch CR, et al. The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 2005;61:103-111.
– reference: Rosenberg L, Weissler M, Hayes DN, et al. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies. Head Neck 2012;34:872-876.
– reference: Howard DJ, Lund VJ. Reflections on the management of adenoid cystic carcinoma of the nasal cavity and paranasal sinuses. Otolaryngol Head Neck Surg 1985;93:338-341.
– reference: Licitra L, Cavina R, Grandi C, et al. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann Oncol 1996;7:640-642.
– reference: Namazie A, Alavi S, Abemayor E, Calcaterra TC, Blackwell KE. Adenoid cystic carcinoma of the base of the tongue. Ann Otol Rhinol Laryngol 2001;110:248-253.
– reference: Hotte SJ, Winquist EW, Lamont E, et al. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 2005;23:585-590.
– reference: Terhaard CH, van der Schroeff MP, van Schie K, et al. The prognostic role of comorbidity in salivary gland carcinoma. Cancer 2008;113:1572-1579.
– reference: Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg 1992;164:623-628.
– reference: Kakarala K, Bhattacharyya N. Survival in oral cavity minor salivary gland carcinoma. Otolaryngol Head Neck Surg 2010;143:122-126.
– reference: Chen AM, Garcia J, Bucci MK, et al. Recurrent salivary gland carcinomas treated by surgery with or without intraoperative radiation therapy. Head Neck 2008;30:2-9.
– reference: Pitman KT, Prokopakis EP, Aydogan B, et al. The role of skull base surgery for the treatment of adenoid cystic carcinoma of the sinonasal tract. Head Neck 1999;21:402-407.
– reference: Hisatomi M, Asaumi J, Yanagi Y, et al. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors. Oral Oncol 2007;43:940-947.
– reference: Fujita G, Sato S, Kishino M, et al. Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland. Mod Pathol 2011;24:885-891.
– reference: North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1990;18:1319-1326.
– reference: de Vries EJ, Johnson JT, Myers EN, Barnes EL Jr, Mandell-Brown M. Base of tongue salivary gland tumors. Head Neck Surg 1987;9:329-331.
– reference: Spiro RH, Huvos AG, Berk R, Strong EW. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg 1978;136:461-468.
– reference: Agulnik M, Cohen EW, Cohen RB, et al. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol 2007;25:3978-3984.
– reference: Evans HL. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. Am J Clin Pathol 1984;81:696-701.
– reference: da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, de Almeida OP, Kowalski LP. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol 2006;42:139-146.
– reference: Hellquist HB, Sundelin K, Di BA, Tytor M, Manzotti M, Viale G. Tumor growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 1997;181:323-329.
– reference: Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 2011;12:815-824.
– reference: Alaeddini M, Khalili M, Tirgary F, Etemad-Moghadam S. Argyrophilic proteins of nucleolar organizer regions (AgNORs) in salivary gland mucoepidermoid carcinoma and its relation to histological grade. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:758-762.
– reference: Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 2008;53:567-577.
– reference: Erovic BM, Schopper C, Pammer J, et al. Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease. Head Neck 2010;32:1167-1172.
– reference: Healey WV, Perzin KH, Smith L. Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical-pathologic correlation, and results of treatment. Cancer 1970;26:368-388.
– reference: Locati LD, Bossi P, Perrone F, et al. Cetuximab in recurrent and/or metastatic salivary gland carcinomas: a phase II study. Oral Oncol 2009;45:574-578.
– reference: Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F. Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy. Am J Otolaryngol 1999;20:281-286.
– reference: Matsuzaki H, Hara M, Yanagi Y, et al. Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-Hodgkin lymphoma in oral and maxillofacial regions. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:126-133.
– reference: Nordgård S, Franzén G, Boysen M, Halvorsen TB. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 1997;107:531-536.
– reference: Pederson AW, Salama JK, Haraf DJ, et al. Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies. Head Neck Oncol 2011;3:31.
– reference: Licitra L, Grandi C, Prott FJ, Schornagel JH, Bruzzi P, Molinari R. Major and minor salivary glands tumors. Crit Rev Oncol Hematol 2003;45:215-225.
– reference: Jensen AD, Nikoghosyan AV, Ecker S, et al. Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response. Radiat Oncol 2011;6:149.
– reference: Sumi M, Van Cauteren M, Sumi T, Obara M, Ichikawa Y, Nakamura T. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors. Radiology 2012;263:770-777.
– reference: Cho KJ, Lee SS, Lee YS. Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 1999;21:414-419.
– reference: DeAngelis AF, Tsui A, Wiesenfeld D, Chandu A. Outcomes of patients with adenoid cystic carcinoma of the minor salivary glands. Int J Oral Maxillofac Surg 2011;40:710-714.
– reference: Kiyoshima T, Shima K, Kobayashi I, et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 2001;37:315-322.
– reference: Keyes JWJr, Harkness BA, Greven KM, Williams DW III, Watson NE Jr, McGuirt WF. Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994;192:99-102.
– reference: Vander Poorten V, Bradley PJ, Takes RP, Rinaldo A, Woolgar JA, Ferlito A. Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology. Head Neck 2012;34:429-440.
– reference: Beckhardt RN, Weber RS, Zane R, et al. Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope 1995;105:1155-1160.
– reference: Zang G, Miao L, Mu Y, et al. Adenoviral mediated transduction of adenoid cystic carcinoma by human TRAIL gene driven with hTERT tumor specific promoter induces apoptosis. Cancer Biol Ther 2009;8:966-972.
– reference: McHugh CH, Roberts DB, El-Naggar AK, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer 2012;118:3928-3936.
– reference: Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Loning T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 2005;103:2526-2533.
– reference: Ghosal N, Mais K, Shenjere P, et al. Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma. Br J Oral Maxillofac Surg 2011;49:510-515.
– reference: Simpson JR, Thawley SE, Matsuba HM. Adenoid cystic salivary gland carcinoma: treatment with irradiation and surgery. Radiology 1984;151:509-512.
– reference: Batsakis JG. Staging of salivary gland neoplasms: role of histopathologic and molecular factors. Am J Surg 1994;168:386-390.
– reference: Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998;82:1217-1224.
– reference: Hill ME, Constenla DO, A'Hern RP, et al. Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol 1997;33:275-278.
– reference: Lloyd S, Yu JB, Ross DA, Wilson LD, Decker RH. A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. Int J Radiat Oncol Biol Phys 2010;76:169-175.
– reference: Kumar M, Stivaros N, Barrett AW, Thomas GJ, Bounds G, Newman L. Polymorphous low-grade adenocarcinoma-a rare and aggressive entity in adolescence. Br J Oral Maxillofac Surg 2004;42:195-199.
– reference: Matsuba HM, Simpson JR, Mauney M, Thawley SE. Adenoid cystic salivary gland carcinoma: a clinicopathologic correlation. Head Neck Surg 1986;8:200-204.
– reference: Hoffman HT, Karnell LH, Robinson RA, Pinkston JA, Menck HR. National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma. Head Neck 1999;21:297-309.
– reference: Laramore GE, Krall JM, Griffin TW, et al. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 1993;27:235-240.
– reference: Waldron CA, el Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol 1988;66:323-333.
– reference: Ganly I, Patel SG, Coleman M, Ghossein R, Carlson D, Shah JP. Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg 2006;132:767-770.
– reference: Kessler DJ, Mickel RA, Calcaterra TC. Malignant salivary gland tumors of the base of the tongue. Arch Otolaryngol 1985;111:664-666.
– reference: Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol 2009;3:69-77.
– reference: Pederson AW, Haraf DJ, Blair EA, et al. Chemoreirradiation for recurrent salivary gland malignancies. Radiother Oncol 2010;95:308-311.
– reference: Leivo I. Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer. Acta Oncol 2006;45:662-668.
– reference: Batsakis JG, Luna MA, El-Naggar AK. Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol 1990;99:1007-1009.
– reference: Spiro RH. Changing trends in the management of salivary tumors. Semin Surg Oncol 1995;11:240-245.
– reference: Loh KS, Barker E, Bruch G, et al. Prognostic factors in malignancy of the minor salivary glands. Head Neck 2009;31:58-63.
– reference: Mahlstedt K, Ussmuller J, Donath K. Malignant sialogenic tumors of the larynx. J Laryngol Otol 2002;116:119-122.
– reference: Barnes L, Eveson JW, Reichart P, Sidranski P. World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Lyon: IARC Press; 2005. p 210.
– reference: Lopes MA, Kowalski LP, da Cunha Santos G, Paes de Almeida O. A clinicopathologic study of 196 intraoral minor salivary gland tumors. J Oral Pathol Med 1999;28:264-267.
– reference: Luukkaa H, Klemi P, Leivo I, Vahlberg T, Grénman R. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol 2006;45:669-675.
– reference: Spiro RH. Management of malignant tumors of the salivary glands. Oncology (Huntingt) 1998;12:671-683.
– reference: Ben-Izhak O, Laster Z, Araidy S, Nagler RM. TUNEL-an efficient prognosis predictor of salivary malignancies. Br J Cancer 2007;96:1101-1106.
– reference: Pantvaidya GH, Vaidya AD, Metgudmath R, Kane SV, D'Cruz AK. Minor salivary gland tumors of the sinonasal region: results of a retrospective analysis with review of literature. Head Neck 2012 Jan 31 [Epub ahead of print].
– reference: Argiris A, Ghebremichael M, Burtness B, Axelrod RS, Deconti RC, Forastiere AA. A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303). Cancer 2011;117:3374-3382.
– reference: Airoldi M, Pedani F, Succo G, et al. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer 2001;91:541-547.
– reference: Lamarre ED, Batra PS, Lorenz RR, et al. Role of positron emission tomography in management of sinonasal neoplasms-a single institution's experience. Am J Otolaryngol 2012;33:289-295.
– reference: Ellis ER, Million RR, Mendenhall WM, Parsons JT, Cassisi NJ. The use of radiation therapy in the management of minor salivary gland tumors. Int J Radiat Oncol Biol Phys 1988;15:613-617.
– reference: de Diego JI, Bernaldez R, Prim MP, Hardisson D. Polymorphous low-grade adenocarcinoma of the tongue. J Laryngol Otol 1996;110:700-703.
– reference: Terhaard CH. Postoperative and primary radiotherapy for salivary gland carcinomas: indications, techniques, and results. Int J Radiat Oncol Biol Phys 2007;69 (2 Suppl):S52-S55.
– reference: Ochel HJ, Gademann G, Rocken C, Wordehoff H. Effects of imatinib mesylate on adenoid cystic carcinomas. Anticancer Res 2005;25:3659-3664.
– reference: Matsuzaki H, Yanagi Y, Hara M, et al. Diagnostic value of dynamic contrast-enhanced MRI for submucosal palatal tumors. Eur J Radiol 2012;81:3306-3312.
– reference: Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer 2012;118:4444-4451.
– reference: Pfeffer MR, Talmi Y, Catane R, Symon Z, Yosepovitch A, Levitt M. A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol 2007;43:33-36.
– reference: Li Q, Zhang XR, Liu XK, et al. Long-term treatment outcome of minor salivary gland carcinoma of the hard palate. Oral Oncol 2012;48:456-462.
– reference: Le QT, Birdwell S, Terris DJ, et al. Postoperative irradiation of minor salivary gland malignancies of the head and neck. Radiother Oncol 1999;52:165-171.
– reference: Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001;25:835-845.
– reference: Iyer NG, Kim L, Nixon IJ, et al. Factors predicting outcome in malignant minor salivary gland tumors of the oropharynx. Arch Otolaryngol Head Neck Surg 2010;136:1240-1247.
– reference: Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer 1978;42:265-282.
– reference: Bradley PJ. Submandibular gland and minor salivary gland neoplasms. Curr Opin Otolaryngol Head Neck Surg 1999;7:72-78.
– reference: Debaere D, Vander Poorten V, Nuyts S, et al. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer. B-ENT 2011;7:1-6.
– reference: Anderson JN Jr, Beenken SW, Crowe R, et al. Prognostic factors in minor salivary gland cancer. Head Neck 1995;17:480-486.
– reference: Vander Poorten VLM, Balm AJM, Hilgers FJM, Tan IB, Keus RB, Hart AAM. Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer 2000;89:1195-1204.
– reference: Carrillo JF, Maldonado F, Carrillo LC, et al. Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx. Head Neck 2011;33:1406-1412.
– reference: Arora SK, Sreedharanunni S, Dey P. Cytomorphological features of an aggressive variant of polymorphous low-grade adenocarcinoma in adolescence with lymph node metastasis. Diagn Cytopathol 2013;41:186-188.
– reference: Buchholz TA, Laramore GE, Griffin BR, Koh WJ, Griffin TW. The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer 1992;69:2779-2788.
– reference: Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck 1986;8:177-184.
– reference: Bradley PJ. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 2004;12:127-132.
– reference: Albeck H, Nielsen NH, Hansen HE, et al. Epidemiology of nasopharyngeal and salivary gland carcinoma in Greenland. Arctic Med Res 1992;51:189-195.
– reference: Rhee CS, Won TB, Lee CH, et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope 2006;116:982-986.
– reference: Abu El-Naaj I, Leiser Y, Wolff A, Peled M. Polymorphous low grade adenocarcinoma: case series and review of surgical management. J Oral Maxillofac Surg 2011;69:1967-1972.
– reference: van der Wal JE, Snow GB, van der Waal I. Histological reclassification of 101 intraoral salivary gland tumors (new WHO classification). J Clin Pathol 1992;45:834-835.
– reference: Freier K, Flechtenmacher C, Walch A, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet 2005;159:89-95.
– reference: Jones AS, Beasley NJ, Houghton DJ, Helliwell TR, Husband DJ. Tumors of the minor salivary glands. Clin Otolaryngol Allied Sci 1998;23:27-33.
– reference: Spiro RH, Koss LG, Hajdu SI, Strong EW. Tumors of minor salivary origin. A clinicopathologic study of 492 cases. Cancer 1973;31:117-129.
– reference: Naficy S, Disher MJ, Esclamado RM. Adenoid cystic carcinoma of the paranasal sinuses. Am J Rhinol 1999;13:311-314.
– reference: Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 2006;24:2673-2678.
– reference: Ma DQ, Yu GY. Tumors of the minor salivary glands. A clinicopathologic study of 243 cases. Acta Otolaryngol 1987;103:325-331.
– reference: Shao C, Sun W, Tan M, et al. Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma. Clin Cancer Res 2011;17:4320-4330.
– reference: Melnick M, Sedghizadeh PP, Allen CM, Jaskoll T. Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Exp Mol Pathol 2011;92:118-125.
– reference: Eapen LJ, Gerig LH, Catton GE, Danjoux CE, Girard A. Impact of local radiation in the management of salivary gland carcinomas. Head Neck Surg 1988;10:239-245.
– reference: Cianchetti M, Sandow PS, Scarborough LD, et al. Radiation therapy for minor salivary gland carcinoma. Laryngoscope 2009;119:1334-1338.
– reference: Copelli C, Bianchi B, Ferrari S, Ferri A, Sesenna E. Malignant tumors of intraoral minor salivary glands. Oral Oncol 2008;44:658-663.
– reference: Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 2004;26:681-693.
– reference: Gil Z, Carlson DL, Gupta A, et al. Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 2009;135:173-179.
– reference: Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992;69:2021-2030.
– reference: Persson F, Fehr A, Sundelin K, Schulte B, Loning T, Stenman G. Studies of genomic imbalances and the MYB-NFIB gene fusion in polymorphous low-grade adenocarcinoma of the head and neck. Int J Oncol 2012;40:80-84.
– reference: Skalova A, Lehtonen H, von Boguslawsky K, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 1994;25:929-935.
– reference: Wang CC, See LC, Hong JH, Tang SG. Nasopharyngeal adenoid cystic carcinoma: five new cases and a literature review. J Otolaryngol 1996;25:399-403.
– reference: Alcedo JC, Fábrega JM, Arosemena JR, Urrutia A. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Head Neck 2004;26:829-831.
– reference: Lin CH, Yen RF, Jeng YM, Tzen CY, Hsu C, Hong RL. Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate. Head Neck 2005;27:1022-1027.
– reference: Triantafillidou K, Iordanidis F, Psomaderis K, Kalimeras E. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study. J Oral Maxillofac Surg 2010;68:2489-2496.
– reference: Lopes MA, Santos GC, Kowalski LP. Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 1998;20:699-706.
– reference: Chen AM, Garcia J, Granchi P, Bucci MK, Lee NY. Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy. Clin Otolaryngol 2009;34:539-545.
– reference: Patel SG, Singh B, Polluri A, et al. Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer 2003;98:1179-1187.
– reference: Mucke T, Tannapfel A, Kesting MR, et al. Adenoid cystic carcinomas of minor salivary glands. Auris Nasus Larynx 2010;37:615-620.
– reference: Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984;54:1062-1069.
– reference: Glisson B, Colevas AD, Haddad R, et al. HER2 expression in salivary gland carcinomas: dependence on histological subtype. Clin Cancer Res 2004;10:944-946.
– reference: Ross PJ, Teoh EM, A'Hern RP, et al. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma. Clin Oncol (R Coll Radiol) 2009;21:311-314.
– reference: Borthne A, Kjellevold K, Kaalhus O, Vermund H. Salivary gland malignant neoplasms: treatment and prognosis. Int J Radiat Oncol Biol Phys 1986;12:747-754.
– reference: Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005;104:338-344.
– reference: Suárez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004;26:136-144.
– reference: Blanchaert RH, Ord RA, Kumar D. Polymorphous low-grade adenocarcinoma of the sublingual gland. Int J Oral Maxillofac Surg 1998;27:115-117.
– reference: Bj⊘rndal K, Krogdahl A, Therkildsen MH, et al. Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 2012;48:179-185.
– reference: Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck 2007;29:907-912.
– reference: Fu KK, Leibel SA, Levine ML, Friedlander LM, Boles R, Phillips TL. Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer 1977;40:2882-2890.
– reference: Jones AS, Hamilton JW, Rowley H, Husband D, Helliwell TR. Adenoid cystic carcinoma of the head and neck. Clin Otolaryngol Allied Sci 1997;22:434-443.
– reference: Alavi S, Namazie A, Calcaterra TC, Blackwell KE. Glandular carcinoma of the larynx: the UCLA experience. Ann Otol Rhinol Laryngol 1999;108:485-489.
– reference: Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer 1999;86:207-219.
– reference: Schwarz S, Müller M, Ettl T, Stockmann P, Zenk J, Agaimy A. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Int J Clin Exp Pathol 2011;4:336-348.
– reference: Kokemueller H, Brueggemann N, Swennen G, Eckardt A. Mucoepidermoid carcinoma of the salivary glands-clinical review of 42 cases. Oral Oncol 2005;41:3-10.
– reference: Murakami M, Ohtani I, Hojo H, Wakasa H. Immunohistochemical evaluation with Ki-67: an application to salivary gland tumors. J Laryngol Otol 1992;106:35-38.
– reference: Yin ZY, Wu XL, Hu YH, Gu XZ. Cylindroma of the nasopharynx: a chronic disease. Int J Radiat Oncol Biol Phys 1986;12:25-30.
– reference: Batsakis JG, Luna MA. Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol 1990;99:835-838.
– reference: Saghravanian N, Mohtasham N, Jafarzadeh H. Comparison of immunohistochemical markers between adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. J Oral Sci 2009;51:509-514.
– reference: Sadeghi A, Tran LM, Mark R, Sidrys J, Parker RG. Minor salivary gland tumors of the head and neck: treatment strategies and prognosis. Am J Clin Oncol 1993;16:3-8.
– reference: Olusanya AA, Akadiri OA, Akinmoladun VI, Adeyemi BF. Polymorphous low grade adenocarcinoma: literature review and report of lower lip lesion with suspected lung metastasis. J Maxillofac Oral Surg 2011;10:60-63.
– volume: 70
  start-page: 379
  year: 1992
  end-page: 385
  article-title: The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition
  publication-title: Cancer
– volume: 17
  start-page: 4320
  year: 2011
  end-page: 4330
  article-title: Integrated, genome‐wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma
  publication-title: Clin Cancer Res
– volume: 268
  start-page: 1241
  year: 2011
  end-page: 1244
  article-title: First‐bite syndrome in oncologic patients
  publication-title: Eur Arch Otorhinolaryngol
– volume: 111
  start-page: 460
  year: 1994
  end-page: 466
  article-title: High correlation with survival of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of the parotid gland
  publication-title: Otolaryngol Head Neck Surg
– volume: 99
  start-page: 929
  year: 1990
  end-page: 933
  article-title: Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas
  publication-title: Ann Otol Rhinol Laryngol
– volume: 92
  start-page: 118
  year: 2011
  end-page: 125
  article-title: Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell‐specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship
  publication-title: Exp Mol Pathol
– volume: 21
  start-page: 255
  year: 1999
  end-page: 263
  article-title: Neutron radiotherapy for the treatment of locally advanced major salivary gland tumors
  publication-title: Head Neck
– volume: 49
  start-page: 510
  year: 2011
  end-page: 515
  article-title: Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma
  publication-title: Br J Oral Maxillofac Surg
– volume: 45
  start-page: 834
  year: 1992
  end-page: 835
  article-title: Histological reclassification of 101 intraoral salivary gland tumors (new WHO classification)
  publication-title: J Clin Pathol
– volume: 76
  start-page: 169
  year: 2010
  end-page: 175
  article-title: A prognostic index for predicting lymph node metastasis in minor salivary gland cancer
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 66
  start-page: 1044
  year: 2006
  end-page: 1050
  article-title: Long‐term outcome of patients treated by radiation therapy alone for salivary gland carcinomas
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 43
  start-page: 940
  year: 2007
  end-page: 947
  article-title: Diagnostic value of dynamic contrast‐enhanced MRI in the salivary gland tumors
  publication-title: Oral Oncol
– volume: 93
  start-page: 338
  year: 1985
  end-page: 341
  article-title: Reflections on the management of adenoid cystic carcinoma of the nasal cavity and paranasal sinuses
  publication-title: Otolaryngol Head Neck Surg
– volume: 99
  start-page: 1007
  year: 1990
  end-page: 1009
  article-title: Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas
  publication-title: Ann Otol Rhinol Laryngol
– volume: 537
  start-page: 67
  year: 1998
  end-page: 74
  article-title: Analysis of factors affecting long‐term treatment results of adenoid cystic carcinoma of the nose and paranasal sinuses
  publication-title: Acta Otolaryngol Suppl
– volume: 61
  start-page: 103
  year: 2005
  end-page: 111
  article-title: The role of radiotherapy in the treatment of malignant salivary gland tumors
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 12
  start-page: 815
  year: 2011
  end-page: 824
  article-title: Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
  publication-title: Lancet Oncol
– volume: 119
  start-page: 1334
  year: 2009
  end-page: 1338
  article-title: Radiation therapy for minor salivary gland carcinoma
  publication-title: Laryngoscope
– volume: 113
  start-page: 126
  year: 2012
  end-page: 133
  article-title: Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non‐Hodgkin lymphoma in oral and maxillofacial regions
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol
– volume: 54
  start-page: 448
  year: 1996
  end-page: 453
  article-title: Carcinoma of the minor salivary glands: results of surgery and combined therapy
  publication-title: J Oral Maxillofac Surg
– volume: 45
  start-page: 574
  year: 2009
  end-page: 578
  article-title: Cetuximab in recurrent and/or metastatic salivary gland carcinomas: a phase II study
  publication-title: Oral Oncol
– volume: 104
  start-page: 338
  year: 2005
  end-page: 344
  article-title: Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques
  publication-title: Cancer
– volume: 116
  start-page: 982
  year: 2006
  end-page: 986
  article-title: Adenoid cystic carcinoma of the sinonasal tract: treatment results
  publication-title: Laryngoscope
– volume: 108
  start-page: 485
  year: 1999
  end-page: 489
  article-title: Glandular carcinoma of the larynx: the UCLA experience
  publication-title: Ann Otol Rhinol Laryngol
– volume: 25
  start-page: 399
  year: 1996
  end-page: 403
  article-title: Nasopharyngeal adenoid cystic carcinoma: five new cases and a literature review
  publication-title: J Otolaryngol
– volume: 31
  start-page: 58
  year: 2009
  end-page: 63
  article-title: Prognostic factors in malignancy of the minor salivary glands
  publication-title: Head Neck
– volume: 10
  start-page: 250
  year: 1989
  end-page: 256
  article-title: Minor salivary gland tumors: the role of radiotherapy
  publication-title: Am J Otolaryngol
– volume: 18
  start-page: 1319
  year: 1990
  end-page: 1326
  article-title: Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 34
  start-page: 1648
  year: 2012
  end-page: 1651
  article-title: Minor salivary gland malignancies in the pediatric population
  publication-title: Head Neck
– volume: 151
  start-page: 509
  year: 1984
  end-page: 512
  article-title: Adenoid cystic salivary gland carcinoma: treatment with irradiation and surgery
  publication-title: Radiology
– volume: 136
  start-page: 461
  year: 1978
  end-page: 468
  article-title: Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases
  publication-title: Am J Surg
– volume: 40
  start-page: 710
  year: 2011
  end-page: 714
  article-title: Outcomes of patients with adenoid cystic carcinoma of the minor salivary glands
  publication-title: Int J Oral Maxillofac Surg
– volume: 12
  start-page: 747
  year: 1986
  end-page: 754
  article-title: Salivary gland malignant neoplasms: treatment and prognosis
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 123
  start-page: 615
  year: 1997
  end-page: 620
  article-title: Prognostic significance of nucleolar organizer regions in adenoid cystic carcinomas of the head and neck
  publication-title: Arch Otolaryngol Head Neck Surg
– volume: 21
  start-page: 402
  year: 1999
  end-page: 407
  article-title: The role of skull base surgery for the treatment of adenoid cystic carcinoma of the sinonasal tract
  publication-title: Head Neck
– volume: 17
  start-page: 480
  year: 1995
  end-page: 486
  article-title: Prognostic factors in minor salivary gland cancer
  publication-title: Head Neck
– volume: 83
  start-page: s125
  issue: Suppl 1
  year: 1996
  end-page: s129
  article-title: European results in neutron therapy of malignant salivary gland tumors
  publication-title: Bull Cancer Radiother
– volume: 20
  start-page: 281
  year: 1999
  end-page: 286
  article-title: Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy
  publication-title: Am J Otolaryngol
– volume: 98
  start-page: 1179
  year: 2003
  end-page: 1187
  article-title: Craniofacial surgery for malignant skull base tumors: report of an international collaborative study
  publication-title: Cancer
– volume: 116
  start-page: 119
  year: 2002
  end-page: 122
  article-title: Malignant sialogenic tumors of the larynx
  publication-title: J Laryngol Otol
– volume: 263
  start-page: 770
  year: 2012
  end-page: 777
  article-title: Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors
  publication-title: Radiology
– volume: 134
  start-page: 622
  year: 2006
  end-page: 626
  article-title: Clinicopathologic and immunohistochemical study of intraoral mucoepidermoid carcinoma
  publication-title: Otolaryngol Head Neck Surg
– volume: 10
  start-page: 60
  year: 2011
  end-page: 63
  article-title: Polymorphous low grade adenocarcinoma: literature review and report of lower lip lesion with suspected lung metastasis
  publication-title: J Maxillofac Oral Surg
– volume: 27
  start-page: 1022
  year: 2005
  end-page: 1027
  article-title: Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate
  publication-title: Head Neck
– volume: 159
  start-page: 89
  year: 2005
  end-page: 95
  article-title: Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis
  publication-title: Cancer Genet Cytogenet
– volume: 135
  start-page: 687
  year: 2009
  end-page: 692
  article-title: Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma
  publication-title: Arch Otolaryngol Head Neck Surg
– volume: 15
  start-page: 613
  year: 1988
  end-page: 617
  article-title: The use of radiation therapy in the management of minor salivary gland tumors
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 143
  start-page: 122
  year: 2010
  end-page: 126
  article-title: Survival in oral cavity minor salivary gland carcinoma
  publication-title: Otolaryngol Head Neck Surg
– volume: 135
  start-page: 173
  year: 2009
  end-page: 179
  article-title: Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses
  publication-title: Arch Otolaryngol Head Neck Surg
– volume: 164
  start-page: 623
  year: 1992
  end-page: 628
  article-title: Stage means more than grade in adenoid cystic carcinoma
  publication-title: Am J Surg
– volume: 3
  start-page: 69
  year: 2009
  end-page: 77
  article-title: An update on grading of salivary gland carcinomas
  publication-title: Head Neck Pathol
– volume: 66
  start-page: 323
  year: 1988
  end-page: 333
  article-title: Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases
  publication-title: Oral Surg Oral Med Oral Pathol
– volume: 26
  start-page: 368
  year: 1970
  end-page: 388
  article-title: Mucoepidermoid carcinoma of salivary gland origin. Classification, clinical‐pathologic correlation, and results of treatment
  publication-title: Cancer
– volume: 31
  start-page: 117
  year: 1973
  end-page: 129
  article-title: Tumors of minor salivary origin. A clinicopathologic study of 492 cases
  publication-title: Cancer
– volume: 103
  start-page: 2526
  year: 2005
  end-page: 2533
  article-title: Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases
  publication-title: Cancer
– volume: 10
  start-page: 944
  year: 2004
  end-page: 946
  article-title: HER2 expression in salivary gland carcinomas: dependence on histological subtype
  publication-title: Clin Cancer Res
– volume: 34
  start-page: 429
  year: 2012
  end-page: 440
  article-title: Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology
  publication-title: Head Neck
– volume: 25
  start-page: 929
  year: 1994
  end-page: 935
  article-title: Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections
  publication-title: Hum Pathol
– year: 2012
  article-title: Minor salivary gland tumors of the sinonasal region: results of a retrospective analysis with review of literature
  publication-title: Head Neck
– volume: 28
  start-page: 264
  year: 1999
  end-page: 267
  article-title: A clinicopathologic study of 196 intraoral minor salivary gland tumors
  publication-title: J Oral Pathol Med
– volume: 32
  start-page: 328
  year: 2003
  end-page: 331
  article-title: HER2/neu and Ki‐67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands
  publication-title: J Otolaryngol
– volume: 11
  start-page: 240
  year: 1995
  end-page: 245
  article-title: Changing trends in the management of salivary tumors
  publication-title: Semin Surg Oncol
– volume: 45
  start-page: 669
  year: 2006
  end-page: 675
  article-title: Prognostic significance of Ki‐67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases
  publication-title: Acta Oncol
– volume: 37
  start-page: 615
  year: 2010
  end-page: 620
  article-title: Adenoid cystic carcinomas of minor salivary glands
  publication-title: Auris Nasus Larynx
– volume: 51
  start-page: 189
  year: 1992
  end-page: 195
  article-title: Epidemiology of nasopharyngeal and salivary gland carcinoma in Greenland
  publication-title: Arctic Med Res
– volume: 22
  start-page: 693
  year: 2008
  end-page: 698
  article-title: Correlation between FDG‐PET findings and GLUT1 expression in salivary gland pleomorphic adenomas
  publication-title: Ann Nucl Med
– volume: 24
  start-page: 885
  year: 2011
  end-page: 891
  article-title: Lymphatic vessels and related factors in adenoid cystic carcinoma of the salivary gland
  publication-title: Mod Pathol
– volume: 30
  start-page: 492
  year: 2008
  end-page: 496
  article-title: Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy
  publication-title: Head Neck
– volume: 35
  start-page: 443
  year: 1996
  end-page: 454
  article-title: Management of minor salivary gland carcinomas
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 6
  start-page: 149
  year: 2011
  article-title: Raster‐scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response
  publication-title: Radiat Oncol
– volume: 37
  start-page: 315
  year: 2001
  end-page: 322
  article-title: Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands
  publication-title: Oral Oncol
– volume: 53
  start-page: 567
  year: 2008
  end-page: 577
  article-title: Overexpression of EGFR and absence of C‐KIT expression correlate with poor prognosis in salivary gland carcinomas
  publication-title: Histopathology
– volume: 69
  start-page: S52
  issue: 2 Suppl
  year: 2007
  end-page: S55
  article-title: Postoperative and primary radiotherapy for salivary gland carcinomas: indications, techniques, and results
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 68
  start-page: 2053
  year: 2010
  end-page: 2057
  article-title: Acinic cell carcinoma of minor salivary glands: a clinicopathologic study of 21 cases
  publication-title: J Oral Maxillofac Surg
– volume: 181
  start-page: 323
  year: 1997
  end-page: 329
  article-title: Tumor growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki‐67 and bcl‐2 expression and of in situ end labelling (TUNEL)
  publication-title: J Pathol
– start-page: 54
  year: 2009
  end-page: 57
– volume: 21
  start-page: 297
  year: 1999
  end-page: 309
  article-title: National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma
  publication-title: Head Neck
– volume: 117
  start-page: 3374
  year: 2011
  end-page: 3382
  article-title: A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)
  publication-title: Cancer
– volume: 30
  start-page: 2
  year: 2008
  end-page: 9
  article-title: Recurrent salivary gland carcinomas treated by surgery with or without intraoperative radiation therapy
  publication-title: Head Neck
– volume: 7
  start-page: 1
  year: 2011
  end-page: 6
  article-title: Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer
  publication-title: B‐ENT
– volume: 192
  start-page: 99
  year: 1994
  end-page: 102
  article-title: Salivary gland tumors: pretherapy evaluation with PET
  publication-title: Radiology
– volume: 110
  start-page: 248
  year: 2001
  end-page: 253
  article-title: Adenoid cystic carcinoma of the base of the tongue
  publication-title: Ann Otol Rhinol Laryngol
– volume: 16
  start-page: 3
  year: 1993
  end-page: 8
  article-title: Minor salivary gland tumors of the head and neck: treatment strategies and prognosis
  publication-title: Am J Clin Oncol
– volume: 43
  start-page: 463
  year: 2007
  end-page: 470
  article-title: Intra‐oral minor salivary gland tumors: a clinicopathological study of 546 cases
  publication-title: Oral Oncol
– volume: 69
  start-page: 2021
  year: 1992
  end-page: 2030
  article-title: Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases
  publication-title: Cancer
– volume: 54
  start-page: 1062
  year: 1984
  end-page: 1069
  article-title: Histologic grading of adenoid cystic carcinoma of the salivary glands
  publication-title: Cancer
– volume: 23
  start-page: 27
  year: 1998
  end-page: 33
  article-title: Tumors of the minor salivary glands
  publication-title: Clin Otolaryngol Allied Sci
– start-page: 210
  year: 2005
– volume: 33
  start-page: 289
  year: 2012
  end-page: 295
  article-title: Role of positron emission tomography in management of sinonasal neoplasms—a single institution's experience
  publication-title: Am J Otolaryngol
– volume: 51
  start-page: 509
  year: 2009
  end-page: 514
  article-title: Comparison of immunohistochemical markers between adenoid cystic carcinoma and polymorphous low‐grade adenocarcinoma
  publication-title: J Oral Sci
– volume: 8
  start-page: 177
  year: 1986
  end-page: 184
  article-title: Salivary neoplasms: overview of a 35‐year experience with 2,807 patients
  publication-title: Head Neck
– start-page: 1
  year: 1996
  end-page: 23
– volume: 64
  start-page: 1114
  year: 2006
  end-page: 1120
  article-title: Management of adenoid cystic carcinoma of minor salivary glands
  publication-title: J Oral Maxillofac Surg
– volume: 59
  start-page: 161
  year: 2001
  end-page: 167
  article-title: Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?
  publication-title: Radiother Oncol
– volume: 86
  start-page: 207
  year: 1999
  end-page: 219
  article-title: Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases
  publication-title: Cancer
– volume: 105
  start-page: 1155
  year: 1995
  end-page: 1160
  article-title: Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome
  publication-title: Laryngoscope
– volume: 25
  start-page: 835
  year: 2001
  end-page: 845
  article-title: Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading
  publication-title: Am J Surg Pathol
– volume: 24
  start-page: 2673
  year: 2006
  end-page: 2678
  article-title: Systemic therapy in the palliative management of advanced salivary gland cancers
  publication-title: J Clin Oncol
– volume: 42
  start-page: 265
  year: 1978
  end-page: 282
  article-title: Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course
  publication-title: Cancer
– volume: 45
  start-page: 662
  year: 2006
  end-page: 668
  article-title: Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer
  publication-title: Acta Oncol
– volume: 82
  start-page: 1217
  year: 1998
  end-page: 1224
  article-title: Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria
  publication-title: Cancer
– volume: 12
  start-page: 671
  year: 1998
  end-page: 683
  article-title: Management of malignant tumors of the salivary glands
  publication-title: Oncology (Huntingt)
– volume: 4
  start-page: 336
  year: 2011
  end-page: 348
  article-title: Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow‐up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low‐grade adenocarcinoma
  publication-title: Int J Clin Exp Pathol
– volume: 66
  start-page: 2031
  year: 1990
  end-page: 2033
  article-title: Intraoral adenoid cystic carcinoma. The presence of perineural spread in relation to site, size, local extension, and metastatic spread in 22 cases
  publication-title: Cancer
– volume: 106
  start-page: 242
  year: 2008
  end-page: 245
  article-title: Fine‐needle aspiration biopsy as an auxiliary diagnostic tool on intraoral minor salivary gland adenoid cystic carcinoma
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 45
  start-page: 669
  year: 2009
  end-page: 674
  article-title: Survival from salivary glands adenoid cystic carcinoma in European populations
  publication-title: Oral Oncol
– volume: 33
  start-page: 1406
  year: 2011
  end-page: 1412
  article-title: Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx
  publication-title: Head Neck
– volume: 27
  start-page: 115
  year: 1998
  end-page: 117
  article-title: Polymorphous low‐grade adenocarcinoma of the sublingual gland
  publication-title: Int J Oral Maxillofac Surg
– volume: 105
  start-page: 758
  year: 2008
  end-page: 762
  article-title: Argyrophilic proteins of nucleolar organizer regions (AgNORs) in salivary gland mucoepidermoid carcinoma and its relation to histological grade
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
– volume: 52
  start-page: 165
  year: 1999
  end-page: 171
  article-title: Postoperative irradiation of minor salivary gland malignancies of the head and neck
  publication-title: Radiother Oncol
– volume: 249
  start-page: 909
  year: 2008
  end-page: 916
  article-title: Parotid gland tumors: can addition of diffusion‐weighted MR imaging to dynamic contrast‐enhanced MR imaging improve diagnostic accuracy in characterization?
  publication-title: Radiology
– volume: 42
  start-page: 139
  year: 2006
  end-page: 146
  article-title: Prognostic factors in head and neck adenoid cystic carcinoma
  publication-title: Oral Oncol
– volume: 3
  start-page: 31
  year: 2011
  article-title: Adjuvant chemoradiotherapy for locoregionally advanced and high‐risk salivary gland malignancies
  publication-title: Head Neck Oncol
– volume: 91
  start-page: 541
  year: 2001
  end-page: 547
  article-title: Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies
  publication-title: Cancer
– volume: 89
  start-page: 1195
  year: 2000
  end-page: 1204
  article-title: Stage as major long term outcome predictor in minor salivary gland carcinoma
  publication-title: Cancer
– volume: 69
  start-page: 1967
  year: 2011
  end-page: 1972
  article-title: Polymorphous low grade adenocarcinoma: case series and review of surgical management
  publication-title: J Oral Maxillofac Surg
– volume: 27
  start-page: 235
  year: 1993
  end-page: 240
  article-title: Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG‐MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 26
  start-page: 447
  year: 1997
  end-page: 449
  article-title: Regional metastasis in polymorphous low grade adenocarcinoma. Report of a case
  publication-title: Int J Oral Maxillofac Surg
– volume: 111
  start-page: 1533
  year: 2001
  end-page: 1544
  article-title: Management of nasopharyngeal salivary gland malignancy
  publication-title: Laryngoscope
– volume: 81
  start-page: 3306
  year: 2012
  end-page: 3312
  article-title: Diagnostic value of dynamic contrast‐enhanced MRI for submucosal palatal tumors
  publication-title: Eur J Radiol
– volume: 81
  start-page: 696
  year: 1984
  end-page: 701
  article-title: Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading
  publication-title: Am J Clin Pathol
– volume: 32
  start-page: 1167
  year: 2010
  end-page: 1172
  article-title: Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease
  publication-title: Head Neck
– volume: 7
  start-page: 640
  year: 1996
  end-page: 642
  article-title: Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients
  publication-title: Ann Oncol
– volume: 96
  start-page: 1101
  year: 2007
  end-page: 1106
  article-title: TUNEL—an efficient prognosis predictor of salivary malignancies
  publication-title: Br J Cancer
– volume: 29
  start-page: 907
  year: 2007
  end-page: 912
  article-title: Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy
  publication-title: Head Neck
– volume: 8
  start-page: 966
  year: 2009
  end-page: 972
  article-title: Adenoviral mediated transduction of adenoid cystic carcinoma by human TRAIL gene driven with hTERT tumor specific promoter induces apoptosis
  publication-title: Cancer Biol Ther
– volume: 168
  start-page: 386
  year: 1994
  end-page: 390
  article-title: Staging of salivary gland neoplasms: role of histopathologic and molecular factors
  publication-title: Am J Surg
– volume: 132
  start-page: 767
  year: 2006
  end-page: 770
  article-title: Malignant minor salivary gland tumors of the larynx
  publication-title: Arch Otolaryngol Head Neck Surg
– volume: 26
  start-page: 829
  year: 2004
  end-page: 831
  article-title: Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases
  publication-title: Head Neck
– volume: 118
  start-page: 4444
  year: 2012
  end-page: 4451
  article-title: Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973–2007 Surveillance, Epidemiology, and End Results data
  publication-title: Cancer
– volume: 23
  start-page: 585
  year: 2005
  end-page: 590
  article-title: Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c‐kit: a Princess Margaret Hospital phase II consortium study
  publication-title: J Clin Oncol
– volume: 42
  start-page: 195
  year: 2004
  end-page: 199
  article-title: Polymorphous low‐grade adenocarcinoma—a rare and aggressive entity in adolescence
  publication-title: Br J Oral Maxillofac Surg
– volume: 43
  start-page: 33
  year: 2007
  end-page: 36
  article-title: A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands
  publication-title: Oral Oncol
– volume: 23
  start-page: 5474
  year: 2005
  end-page: 5483
  article-title: Phase I trial of the oral antiangiogenesis agent AG‐013736 in patients with advanced solid tumors: pharmacokinetic and clinical results
  publication-title: J Clin Oncol
– volume: 95
  start-page: 308
  year: 2010
  end-page: 311
  article-title: Chemoreirradiation for recurrent salivary gland malignancies
  publication-title: Radiother Oncol
– volume: 33
  start-page: 275
  year: 1997
  end-page: 278
  article-title: Cisplatin and 5‐fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma
  publication-title: Oral Oncol
– volume: 22
  start-page: 434
  year: 1997
  end-page: 443
  article-title: Adenoid cystic carcinoma of the head and neck
  publication-title: Clin Otolaryngol Allied Sci
– volume: 25
  start-page: 3659
  year: 2005
  end-page: 3664
  article-title: Effects of imatinib mesylate on adenoid cystic carcinomas
  publication-title: Anticancer Res
– volume: 25
  start-page: 3978
  year: 2007
  end-page: 3984
  article-title: Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands
  publication-title: J Clin Oncol
– volume: 31
  start-page: 257
  year: 2002
  end-page: 261
  article-title: Intraoral minor salivary gland neoplasm: a single institution experience of 80 cases
  publication-title: Int J Oral Maxillofac Surg
– volume: 39
  start-page: 724
  year: 2003
  end-page: 727
  article-title: Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study
  publication-title: Oral Oncol
– volume: 12
  start-page: 25
  year: 1986
  end-page: 30
  article-title: Cylindroma of the nasopharynx: a chronic disease
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 48
  start-page: 456
  year: 2012
  end-page: 462
  article-title: Long‐term treatment outcome of minor salivary gland carcinoma of the hard palate
  publication-title: Oral Oncol
– volume: 13
  start-page: 311
  year: 1999
  end-page: 314
  article-title: Adenoid cystic carcinoma of the paranasal sinuses
  publication-title: Am J Rhinol
– volume: 10
  start-page: 239
  year: 1988
  end-page: 245
  article-title: Impact of local radiation in the management of salivary gland carcinomas
  publication-title: Head Neck Surg
– volume: 116
  start-page: 2145
  year: 2006
  end-page: 2149
  article-title: Retrospective study and review of polymorphous low‐grade adenocarcinoma
  publication-title: Laryngoscope
– volume: 106
  start-page: 35
  year: 1992
  end-page: 38
  article-title: Immunohistochemical evaluation with Ki‐67: an application to salivary gland tumors
  publication-title: J Laryngol Otol
– volume: 136
  start-page: 1240
  year: 2010
  end-page: 1247
  article-title: Factors predicting outcome in malignant minor salivary gland tumors of the oropharynx
  publication-title: Arch Otolaryngol Head Neck Surg
– volume: 14
  start-page: 203
  year: 2010
  end-page: 209
  article-title: Malignant minor salivary gland tumors: a retrospective study of 27 cases
  publication-title: Oral Maxillofac Surg
– volume: 44
  start-page: 658
  year: 2008
  end-page: 663
  article-title: Malignant tumors of intraoral minor salivary glands
  publication-title: Oral Oncol
– volume: 41
  start-page: 3
  year: 2005
  end-page: 10
  article-title: Mucoepidermoid carcinoma of the salivary glands—clinical review of 42 cases
  publication-title: Oral Oncol
– volume: 107
  start-page: 531
  year: 1997
  end-page: 536
  article-title: Ki‐67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections
  publication-title: Laryngoscope
– volume: 40
  start-page: 2882
  year: 1977
  end-page: 2890
  article-title: Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures
  publication-title: Cancer
– volume: 111
  start-page: 664
  year: 1985
  end-page: 666
  article-title: Malignant salivary gland tumors of the base of the tongue
  publication-title: Arch Otolaryngol
– volume: 69
  start-page: 2779
  year: 1992
  end-page: 2788
  article-title: The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms
  publication-title: Cancer
– volume: 8
  start-page: 200
  year: 1986
  end-page: 204
  article-title: Adenoid cystic salivary gland carcinoma: a clinicopathologic correlation
  publication-title: Head Neck Surg
– volume: 162
  start-page: 330
  year: 1991
  end-page: 336
  article-title: The importance of clinical staging of minor salivary gland carcinoma
  publication-title: Am J Surg
– volume: 16
  start-page: 163
  year: 2008
  end-page: 169
  article-title: Polymorphous low‐grade adenocarcinoma of the head and neck
  publication-title: Curr Opin Otolaryngol Head Neck Surg
– volume: 9
  start-page: 82
  year: 1986
  end-page: 92
  article-title: Malignant salivary tumors: analysis of prognostic factors and survival
  publication-title: Head Neck
– volume: 103
  start-page: 325
  year: 1987
  end-page: 331
  article-title: Tumors of the minor salivary glands. A clinicopathologic study of 243 cases
  publication-title: Acta Otolaryngol
– volume: 99
  start-page: 835
  year: 1990
  end-page: 838
  article-title: Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas
  publication-title: Ann Otol Rhinol Laryngol
– volume: 41
  start-page: 186
  year: 2013
  end-page: 188
  article-title: Cytomorphological features of an aggressive variant of polymorphous low‐grade adenocarcinoma in adolescence with lymph node metastasis
  publication-title: Diagn Cytopathol
– volume: 21
  start-page: 311
  year: 2009
  end-page: 314
  article-title: Epirubicin, cisplatin and protracted venous infusion 5‐Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma
  publication-title: Clin Oncol (R Coll Radiol)
– volume: 25
  start-page: 210
  year: 2003
  end-page: 216
  article-title: Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull
  publication-title: Head Neck
– volume: 9
  start-page: 329
  year: 1987
  end-page: 331
  article-title: Base of tongue salivary gland tumors
  publication-title: Head Neck Surg
– volume: 266
  start-page: 333
  year: 2009
  end-page: 341
  article-title: Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved
  publication-title: Eur Arch Otorhinolaryngol
– volume: 21
  start-page: 414
  year: 1999
  end-page: 419
  article-title: Proliferating cell nuclear antigen and c‐erbB‐2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands
  publication-title: Head Neck
– volume: 34
  start-page: 539
  year: 2009
  end-page: 545
  article-title: Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy
  publication-title: Clin Otolaryngol
– volume: 23
  start-page: 6271
  year: 2005
  end-page: 6273
  article-title: Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands
  publication-title: J Clin Oncol
– volume: 114
  start-page: 1194
  year: 2004
  end-page: 1199
  article-title: Role for postoperative radiation therapy in adenoid cystic carcinoma of the head and neck
  publication-title: Laryngoscope
– volume: 20
  start-page: 699
  year: 1998
  end-page: 706
  article-title: Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas
  publication-title: Head Neck
– volume: 73
  start-page: 2563
  year: 1994
  end-page: 2569
  article-title: Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure
  publication-title: Cancer
– volume: 48
  start-page: 179
  year: 2012
  end-page: 185
  article-title: Salivary gland carcinoma in Denmark 1990–2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA)
  publication-title: Oral Oncol
– volume: 7
  start-page: 72
  year: 1999
  end-page: 78
  article-title: Submandibular gland and minor salivary gland neoplasms
  publication-title: Curr Opin Otolaryngol Head Neck Surg
– volume: 40
  start-page: 80
  year: 2012
  end-page: 84
  article-title: Studies of genomic imbalances and the MYB‐NFIB gene fusion in polymorphous low‐grade adenocarcinoma of the head and neck
  publication-title: Int J Oncol
– volume: 12
  start-page: 127
  year: 2004
  end-page: 132
  article-title: Adenoid cystic carcinoma of the head and neck: a review
  publication-title: Curr Opin Otolaryngol Head Neck Surg
– volume: 26
  start-page: 681
  year: 2004
  end-page: 693
  article-title: Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group
  publication-title: Head Neck
– volume: 113
  start-page: 1572
  year: 2008
  end-page: 1579
  article-title: The prognostic role of comorbidity in salivary gland carcinoma
  publication-title: Cancer
– volume: 118
  start-page: 69
  year: 2000
  end-page: 74
  article-title: Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands
  publication-title: Sao Paulo Med J
– volume: 34
  start-page: 872
  year: 2012
  end-page: 876
  article-title: Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies
  publication-title: Head Neck
– volume: 45
  start-page: 215
  year: 2003
  end-page: 225
  article-title: Major and minor salivary glands tumors
  publication-title: Crit Rev Oncol Hematol
– start-page: 721
  year: 1999
  end-page: 748
– volume: 33
  start-page: 211
  year: 2006
  end-page: 214
  article-title: Laryngeal mucoepidermoid carcinoma: report of two cases
  publication-title: Auris Nasus Larynx
– volume: 26
  start-page: 136
  year: 2004
  end-page: 144
  article-title: Prognostic factors in sinonasal tumors involving the anterior skull base
  publication-title: Head Neck
– volume: 110
  start-page: 700
  year: 1996
  end-page: 703
  article-title: Polymorphous low‐grade adenocarcinoma of the tongue
  publication-title: J Laryngol Otol
– volume: 118
  start-page: 3928
  year: 2012
  end-page: 3936
  article-title: Prognostic factors in mucoepidermoid carcinoma of the salivary glands
  publication-title: Cancer
– volume: 68
  start-page: 2489
  year: 2010
  end-page: 2496
  article-title: Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study
  publication-title: J Oral Maxillofac Surg
– ident: e_1_2_3_12_1
  doi: 10.1016/j.oraloncology.2006.11.009
– ident: e_1_2_3_53_1
  doi: 10.1002/1097-0142(197008)26:2<368::AID-CNCR2820260219>3.0.CO;2-K
– ident: e_1_2_3_78_1
  doi: 10.1016/j.oraloncology.2008.10.010
– ident: e_1_2_3_76_1
  doi: 10.1097/00020840-200404000-00013
– ident: e_1_2_3_11_1
  doi: 10.1016/0030-4220(88)90240-X
– ident: e_1_2_3_35_1
  doi: 10.1016/S0167-8140(99)00084-5
– ident: e_1_2_3_49_1
  doi: 10.1177/000348949009901215
– ident: e_1_2_3_163_1
  doi: 10.1001/archotol.1985.00800120058006
– ident: e_1_2_3_43_1
  doi: 10.1097/00000478-200107000-00001
– ident: e_1_2_3_126_1
  doi: 10.1001/archoto.2008.525
– ident: e_1_2_3_79_1
  doi: 10.1038/modpathol.2011.42
– ident: e_1_2_3_51_1
  doi: 10.1177/000348949009901015
– volume: 40
  start-page: 80
  year: 2012
  ident: e_1_2_3_71_1
  article-title: Studies of genomic imbalances and the MYB‐NFIB gene fusion in polymorphous low‐grade adenocarcinoma of the head and neck
  publication-title: Int J Oncol
– ident: e_1_2_3_146_1
  doi: 10.1016/0924-4212(96)84897-3
– ident: e_1_2_3_173_1
  doi: 10.1097/01.mlg.0000216900.03188.48
– ident: e_1_2_3_133_1
  doi: 10.1097/00005537-200407000-00012
– ident: e_1_2_3_152_1
  doi: 10.1002/hed.20651
– ident: e_1_2_3_119_1
  doi: 10.1002/hed.21706
– ident: e_1_2_3_121_1
  doi: 10.1158/1078-0432.CCR-10-2992
– ident: e_1_2_3_151_1
  doi: 10.1016/j.radonc.2010.03.006
– ident: e_1_2_3_111_1
  doi: 10.1002/hed.20274
– ident: e_1_2_3_113_1
  doi: 10.1016/j.oraloncology.2008.07.010
– ident: e_1_2_3_156_1
  doi: 10.1200/JCO.2005.05.3025
– ident: e_1_2_3_184_1
  doi: 10.1002/hed.2890080309
– ident: e_1_2_3_83_1
  doi: 10.1016/j.otohns.2010.02.033
– ident: e_1_2_3_186_1
  doi: 10.1002/hed.21312
– ident: e_1_2_3_172_1
  doi: 10.1016/S0196-0709(99)90028-5
– volume: 4
  start-page: 336
  year: 2011
  ident: e_1_2_3_69_1
  article-title: Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow‐up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low‐grade adenocarcinoma
  publication-title: Int J Clin Exp Pathol
– ident: e_1_2_3_88_1
  doi: 10.1017/S0022215100118535
– ident: e_1_2_3_107_1
  doi: 10.1200/JCO.2005.06.125
– ident: e_1_2_3_147_1
  doi: 10.1002/(SICI)1097-0347(199905)21:3<255::AID-HED11>3.0.CO;2-2
– ident: e_1_2_3_72_1
  doi: 10.1002/(SICI)1097-0347(199908)21:5<402::AID-HED4>3.0.CO;2-Z
– ident: e_1_2_3_122_1
  doi: 10.1016/j.yexmp.2011.10.011
– ident: e_1_2_3_139_1
  doi: 10.1016/S1040-8428(02)00005-7
– ident: e_1_2_3_188_1
  doi: 10.1007/s00405-011-1645-4
– ident: e_1_2_3_131_1
  doi: 10.1002/j.1930-2398.1988.tb00006.x
– ident: e_1_2_3_154_1
  doi: 10.1002/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y
– ident: e_1_2_3_56_1
  doi: 10.1177/000348949009901115
– ident: e_1_2_3_27_1
  doi: 10.1097/00000421-199302000-00002
– ident: e_1_2_3_106_1
  doi: 10.1016/j.oraloncology.2005.12.026
– ident: e_1_2_3_42_1
  doi: 10.1016/S0002-9610(05)80081-9
– ident: e_1_2_3_183_1
  doi: 10.1002/cncr.23771
– ident: e_1_2_3_97_1
  doi: 10.1007/s00405-008-0882-7
– ident: e_1_2_3_112_1
  doi: 10.1016/j.bjoms.2010.09.013
– ident: e_1_2_3_135_1
  doi: 10.1186/1758-3284-3-31
– ident: e_1_2_3_38_1
  doi: 10.1002/hed.10400
– ident: e_1_2_3_187_1
  doi: 10.1002/1097-0142(19901101)66:9<2031::AID-CNCR2820660931>3.0.CO;2-7
– ident: e_1_2_3_92_1
  doi: 10.1590/S1516-31802000000300004
– volume: 25
  start-page: 3659
  year: 2005
  ident: e_1_2_3_110_1
  article-title: Effects of imatinib mesylate on adenoid cystic carcinomas
  publication-title: Anticancer Res
– ident: e_1_2_3_117_1
  doi: 10.1200/JCO.2005.04.192
– ident: e_1_2_3_141_1
  doi: 10.1016/j.ijrobp.2006.06.050
– ident: e_1_2_3_99_1
  doi: 10.1002/(SICI)1097-0347(199908)21:5<414::AID-HED6>3.0.CO;2-M
– ident: e_1_2_3_82_1
  doi: 10.1016/j.otohns.2005.12.012
– ident: e_1_2_3_185_1
  doi: 10.1016/j.anl.2010.02.001
– ident: e_1_2_3_153_1
  doi: 10.1016/S0964-1955(97)00026-2
– ident: e_1_2_3_75_1
  doi: 10.1046/j.1365-2273.1997.00041.x
– ident: e_1_2_3_132_1
  doi: 10.1016/0360-3016(86)90032-5
– ident: e_1_2_3_81_1
  doi: 10.1016/j.oraloncology.2005.06.024
– ident: e_1_2_3_18_1
  doi: 10.1148/radiol.12111248
– ident: e_1_2_3_160_1
  doi: 10.1016/j.oraloncology.2007.08.018
– ident: e_1_2_3_47_1
  doi: 10.1002/1097-0142(197807)42:1<265::AID-CNCR2820420141>3.0.CO;2-Z
– ident: e_1_2_3_74_1
  doi: 10.2500/105065899782102872
– ident: e_1_2_3_123_1
  doi: 10.1016/0196-0709(89)90004-5
– ident: e_1_2_3_164_1
  doi: 10.1177/000348940111000308
– ident: e_1_2_3_19_1
  doi: 10.1016/j.amjoto.2011.08.001
– volume: 7
  start-page: 1
  year: 2011
  ident: e_1_2_3_158_1
  article-title: Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer
  publication-title: B‐ENT
– ident: e_1_2_3_180_1
  doi: 10.1002/lary.20501
– ident: e_1_2_3_130_1
  doi: 10.1016/0360-3016(90)90304-3
– ident: e_1_2_3_22_1
  doi: 10.1002/1097-0142(19940515)73:10<2563::AID-CNCR2820731018>3.0.CO;2-X
– ident: e_1_2_3_33_1
  doi: 10.1016/j.joms.2010.04.003
– ident: e_1_2_3_36_1
  doi: 10.1016/j.oraloncology.2006.04.008
– ident: e_1_2_3_100_1
  doi: 10.1080/02841860500543208
– ident: e_1_2_3_144_1
  doi: 10.1186/1748-717X-6-149
– volume: 51
  start-page: 189
  year: 1992
  ident: e_1_2_3_2_1
  article-title: Epidemiology of nasopharyngeal and salivary gland carcinoma in Greenland
  publication-title: Arctic Med Res
– ident: e_1_2_3_23_1
  doi: 10.1002/hed.2880170605
– ident: e_1_2_3_118_1
  doi: 10.1002/cncr.25852
– ident: e_1_2_3_25_1
  doi: 10.3109/00016488709107802
– ident: e_1_2_3_95_1
  doi: 10.1001/archotol.1997.01900060057010
– ident: e_1_2_3_181_1
  doi: 10.1002/ssu.2980110309
– ident: e_1_2_3_159_1
  doi: 10.1016/S1470-2045(10)70245-X
– ident: e_1_2_3_179_1
  doi: 10.1016/0360-3016(86)90411-6
– ident: e_1_2_3_87_1
  doi: 10.1097/00005537-199704000-00019
– ident: e_1_2_3_128_1
  doi: 10.1016/j.ijrobp.2007.04.079
– ident: e_1_2_3_150_1
  doi: 10.1002/hed.21831
– ident: e_1_2_3_175_1
  doi: 10.1002/cncr.11630
– ident: e_1_2_3_166_1
  doi: 10.1177/000348949910800512
– ident: e_1_2_3_24_1
  doi: 10.1097/00020840-199904000-00007
– ident: e_1_2_3_68_1
  doi: 10.1007/s12663-011-0185-1
– ident: e_1_2_3_124_1
  doi: 10.1016/j.ijrobp.2004.03.018
– ident: e_1_2_3_101_1
  doi: 10.1111/j.1365-2559.2008.03159.x
– volume: 12
  start-page: 671
  year: 1998
  ident: e_1_2_3_5_1
  article-title: Management of malignant tumors of the salivary glands
  publication-title: Oncology (Huntingt)
– ident: e_1_2_3_54_1
  doi: 10.1016/0002-9610(78)90262-3
– ident: e_1_2_3_96_1
  doi: 10.1016/j.tripleo.2007.09.002
– ident: e_1_2_3_14_1
  doi: 10.1016/S0360-3016(96)80005-8
– ident: e_1_2_3_102_1
  doi: 10.1016/0046-8177(94)90014-0
– ident: e_1_2_3_40_1
  doi: 10.1002/hed.20924
– ident: e_1_2_3_155_1
  doi: 10.1093/oxfordjournals.annonc.a010684
– ident: e_1_2_3_140_1
  doi: 10.1016/0360-3016(93)90233-L
– ident: e_1_2_3_114_1
  doi: 10.1158/1078-0432.CCR-03-0253
– ident: e_1_2_3_129_1
  doi: 10.1002/1097-0142(197712)40:6<2882::AID-CNCR2820400618>3.0.CO;2-I
– ident: e_1_2_3_70_1
  doi: 10.2334/josnusd.51.509
– ident: e_1_2_3_90_1
  doi: 10.1016/j.joms.2005.06.017
– ident: e_1_2_3_4_1
  doi: 10.1002/1097-0142(20000915)89:6<1195::AID-CNCR2>3.0.CO;2-J
– ident: e_1_2_3_105_1
  doi: 10.1002/hed.20094
– ident: e_1_2_3_58_1
  doi: 10.1007/s12105-009-0102-9
– start-page: 721
  volume-title: Head and Neck Cancer. A Multidisciplinary Approach
  year: 1999
  ident: e_1_2_3_46_1
– ident: e_1_2_3_77_1
  doi: 10.1002/cncr.27408
– ident: e_1_2_3_182_1
  doi: 10.1002/hed.2890090204
– ident: e_1_2_3_57_1
  doi: 10.1002/(SICI)1097-0347(199907)21:4<297::AID-HED2>3.0.CO;2-R
– ident: e_1_2_3_116_1
  doi: 10.1002/hed.20614
– ident: e_1_2_3_55_1
  doi: 10.1093/ajcp/81.6.696
– ident: e_1_2_3_104_1
  doi: 10.1002/cncr.21116
– ident: e_1_2_3_37_1
  doi: 10.1111/j.1600-0714.1999.tb02036.x
– ident: e_1_2_3_148_1
  doi: 10.1016/S0167-8140(00)00273-5
– ident: e_1_2_3_73_1
  doi: 10.1016/j.ijom.2011.02.010
– ident: e_1_2_3_94_1
  doi: 10.1038/sj.bjc.6603655
– ident: e_1_2_3_62_1
  doi: 10.1097/MOO.0b013e3282f70441
– ident: e_1_2_3_21_1
  doi: 10.1007/s12149-008-0162-z
– ident: e_1_2_3_86_1
  doi: 10.1002/1097-0142(19920415)69:8<2021::AID-CNCR2820690803>3.0.CO;2-7
– ident: e_1_2_3_7_1
  doi: 10.1016/0002-9610(91)90142-Z
– ident: e_1_2_3_115_1
  doi: 10.1016/S1368-8375(03)00097-6
– ident: e_1_2_3_171_1
  doi: 10.1080/00016489850182387
– ident: e_1_2_3_45_1
  doi: 10.1016/S0002-9610(05)80721-4
– ident: e_1_2_3_44_1
  doi: 10.1080/02841860600801316
– ident: e_1_2_3_142_1
  doi: 10.1016/0360-3016(88)90302-1
– ident: e_1_2_3_168_1
  doi: 10.1001/archotol.132.7.767
– ident: e_1_2_3_63_1
  doi: 10.1097/01.mlg.0000243200.35033.2b
– ident: e_1_2_3_85_1
  doi: 10.1002/cncr.26697
– ident: e_1_2_3_50_1
  doi: 10.1002/1097-0142(19920715)70:2<379::AID-CNCR2820700202>3.0.CO;2-C
– ident: e_1_2_3_174_1
  doi: 10.1002/hed.21988
– ident: e_1_2_3_67_1
  doi: 10.1002/dc.22805
– ident: e_1_2_3_65_1
  doi: 10.1016/j.bjoms.2004.01.012
– ident: e_1_2_3_134_1
  doi: 10.1001/archoto.2009.70
– ident: e_1_2_3_170_1
  doi: 10.1177/019459988509300309
– ident: e_1_2_3_10_1
  doi: 10.1016/S0278-2391(96)90119-6
– ident: e_1_2_3_143_1
  doi: 10.1002/cncr.21158
– ident: e_1_2_3_31_1
  doi: 10.1136/jcp.45.9.834
– ident: e_1_2_3_60_1
  doi: 10.1002/(SICI)1097-0142(19990715)86:2<207::AID-CNCR4>3.0.CO;2-Q
– ident: e_1_2_3_138_1
  doi: 10.1097/00005537-200109000-00009
– ident: e_1_2_3_98_1
  doi: 10.2310/7070.2003.11438
– ident: e_1_2_3_169_1
  doi: 10.1016/j.anl.2005.11.005
– start-page: 210
  volume-title: World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors
  year: 2005
  ident: e_1_2_3_6_1
– ident: e_1_2_3_125_1
  doi: 10.1111/j.1749-4486.2009.02036.x
– ident: e_1_2_3_149_1
  doi: 10.1002/hed.20729
– ident: e_1_2_3_137_1
  doi: 10.1002/1097-0142(197301)31:1<117::AID-CNCR2820310116>3.0.CO;2-7
– ident: e_1_2_3_48_1
  doi: 10.1002/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO;2-E
– ident: e_1_2_3_66_1
  doi: 10.1016/j.joms.2010.10.010
– ident: e_1_2_3_8_1
  doi: 10.1002/hed.21641
– ident: e_1_2_3_59_1
  doi: 10.1016/S0901-5027(98)80307-X
– ident: e_1_2_3_120_1
  doi: 10.1016/j.cancergencyto.2004.09.007
– ident: e_1_2_3_157_1
  doi: 10.1016/j.clon.2008.12.009
– ident: e_1_2_3_108_1
  doi: 10.1200/JCO.2007.11.8612
– ident: e_1_2_3_145_1
  doi: 10.1002/1097-0142(19920601)69:11<2779::AID-CNCR2820691125>3.0.CO;2-N
– ident: e_1_2_3_17_1
  doi: 10.1148/radiol.2493072045
– ident: e_1_2_3_176_1
  doi: 10.1002/hed.10358
– ident: e_1_2_3_93_1
  doi: 10.4161/cbt.8.10.8117
– volume: 48
  start-page: 179
  year: 2012
  ident: e_1_2_3_32_1
  article-title: Salivary gland carcinoma in Denmark 1990–2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA)
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2011.09.005
– ident: e_1_2_3_165_1
  doi: 10.1001/archoto.2010.213
– ident: e_1_2_3_177_1
  doi: 10.1002/hed.10193
– ident: e_1_2_3_64_1
  doi: 10.1016/S0901-5027(97)80011-2
– ident: e_1_2_3_127_1
  doi: 10.1148/radiology.151.2.6324280
– ident: e_1_2_3_29_1
  doi: 10.1016/j.tripleo.2008.04.015
– ident: e_1_2_3_162_1
  doi: 10.1002/hed.2890090604
– ident: e_1_2_3_16_1
  doi: 10.1016/j.ejrad.2012.04.009
– ident: e_1_2_3_52_1
  doi: 10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C
– ident: e_1_2_3_39_1
  doi: 10.1007/s10006-010-0217-x
– ident: e_1_2_3_61_1
  doi: 10.1017/S0022215100134681
– ident: e_1_2_3_30_1
  doi: 10.1054/ijom.2002.0223
– ident: e_1_2_3_167_1
  doi: 10.1258/0022215021910078
– ident: e_1_2_3_41_1
  doi: 10.1016/j.oraloncology.2011.12.005
– ident: e_1_2_3_84_1
  doi: 10.1016/j.oraloncology.2004.01.017
– ident: e_1_2_3_109_1
  doi: 10.1200/JCO.2005.01.6055
– ident: e_1_2_3_80_1
  doi: 10.1002/hed.2890080312
– ident: e_1_2_3_9_1
  doi: 10.1002/hed.21980
– ident: e_1_2_3_15_1
  doi: 10.1016/j.tripleo.2011.07.038
– ident: e_1_2_3_26_1
  doi: 10.1288/00005537-199511000-00003
– ident: e_1_2_3_13_1
  doi: 10.1002/(SICI)1097-0347(199812)20:8<699::AID-HED7>3.0.CO;2-P
– ident: e_1_2_3_91_1
  doi: 10.1177/019459989411100412
– ident: e_1_2_3_136_1
  doi: 10.1016/j.ijrobp.2009.01.021
– ident: e_1_2_3_20_1
  doi: 10.1148/radiology.192.1.8208973
– ident: e_1_2_3_34_1
  doi: 10.1046/j.1365-2273.1998.00088.x
– ident: e_1_2_3_161_1
  doi: 10.1016/j.joms.2009.09.065
– start-page: 54
  volume-title: UICC TNM classification of Malignant Tumors
  year: 2009
  ident: e_1_2_3_28_1
– ident: e_1_2_3_89_1
  doi: 10.1016/S1368-8375(00)00083-X
– volume: 25
  start-page: 399
  year: 1996
  ident: e_1_2_3_178_1
  article-title: Nasopharyngeal adenoid cystic carcinoma: five new cases and a literature review
  publication-title: J Otolaryngol
– start-page: 1
  volume-title: Tumors of the Salivary Glands
  year: 1996
  ident: e_1_2_3_3_1
– ident: e_1_2_3_103_1
  doi: 10.1002/(SICI)1096-9896(199703)181:3<323::AID-PATH780>3.0.CO;2-K
SSID ssj0003642
Score 2.405052
SecondaryResourceType review_article
Snippet The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 444
SubjectTerms Biomarkers, Tumor - metabolism
Biopsy, Fine-Needle
carcinoma
Diagnostic Imaging
Humans
Laryngeal Neoplasms - diagnosis
Laryngeal Neoplasms - pathology
Laryngeal Neoplasms - radiotherapy
Laryngeal Neoplasms - surgery
management
minor salivary gland
Oropharyngeal Neoplasms - diagnosis
Oropharyngeal Neoplasms - pathology
Oropharyngeal Neoplasms - radiotherapy
Oropharyngeal Neoplasms - surgery
outcome
Prognosis
salivary gland neoplasms
Salivary Gland Neoplasms - diagnosis
Salivary Gland Neoplasms - pathology
Salivary Gland Neoplasms - radiotherapy
Salivary Gland Neoplasms - surgery
Salivary Glands, Minor
Title Recent trends in the management of minor salivary gland carcinoma
URI https://api.istex.fr/ark:/67375/WNG-5CPZ342G-M/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.23249
https://www.ncbi.nlm.nih.gov/pubmed/23559518
https://www.proquest.com/docview/1498955157
https://www.proquest.com/docview/1500684089
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bSxwxFA6LffHFtnjpWluiFPFl1rkkMwl9El1dhJVSuigihFxRdGdkL2D763uS2RlRFMSHGYaZMyQ5ycn5kpx8QegHdarQnOvIKbgR5WTEjWURS1XMiEqpC2TVw7N8MCKnF_Sig342e2Fqfoh2ws1bRuivvYFLNd1_JA29tqbn4YDfvJdkuefNP_r9SB0Fb-qVTpL5-RXSsArF6X775xNf9MGr9eEloPkUtwbHc_wRXTVZruNNbnvzmerpf8_YHN9Zpk9oZQFI8UHdgj6jji1X0QGgSfBGeBYiZvFNiQEn4nEbKoMrh8c3ZTXBU-nXkiZ_cTgLBGt_NFFZjeUaGh33_xwOosVhC5EmAJGiTBUkdiblcDFpaGaoTQplubSMJ5bEmkuWZ3liHdc8N4XJNGCNRBpFbAKucB0tlVVpvyDMC5lwQwvHJA9dgoNuwiXWKAPDE6K6aK9Ru9ALJnJ_IMadqDmUUwF6EEEPXbTTit7X9BsvCe2Gumsl5OTWx6sVVJyfnQh6-OsyI-mJGHbRVlO5YmGqUxj7cMYBN9Kii7bbz2BkfuVElraagwz1W2lIzCCtjbpRtImlgNgApjIoVaja1_MpBv2j8LD5dtGvaBkgGqmj3rbQ0mwyt98ABs3U99De_wNgSgEQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB9q-6AvWvHrtLZRRHzZ634kuwn4Uvp1au8QabEIJeQTS71dud6B-tc7yd5uqVQQH3ZZ2Fk2mWSSXzKT3wC8Yl5XRgiTeI03qr1KhHU84blOOdU585GsejwpRyf0_Sk7XYG33VmYlh-i33ALlhHH62DgYUN6-4o19Kuzw4AHxC1Yi_65AIk-XZFHFSVtfZ20CDsstOMVSvPt_tNrs9FaUOyPm6DmdeQap56De3DWFbqNOLkYLuZ6aH79wef4v7Vah7tLTEp22k50H1Zc_QB2EFDihETmMWiWnNcEoSKZ9tEypPFkel43M3Kpgjtp9pPEdCDEhOxEdTNVD-HkYP94d5Qs8y0khiJKSgpd0dTbXODFlWWFZS6rtBPKcZE5mhqheFmUmfPCiNJWtjAINzJlNXUZzoaPYLVuavcEiKhUJiyrPFcijgoeRwqfOastrlCoHsCbTu_SLMnIQ06Mb7KlUc4l6kFGPQzgZS_6vWXguEnodWy8XkLNLkLIWsXk58mhZLsfvxQ0P5TjAWx0rSuX1nqJyx_BBUJHVg3gRf8a7Sw4T1TtmgXKsHCahqYc__W47RX9z3IEbYhUOdYqtu3fyylH-3vx4em_i27B7dHx-EgevZt8eAZ3ELHRNghuA1bns4V7jqhorjdj5_8NdkoFLg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3raxQxEB9qC-KXVvF1tmoUEb_sdR_JboKfStvr-ehRxGIRIeRJS73dcr0D9a93kr3dUqkgfthlYWfZZJLJ_JJMfgPwinldGSFM4jXeqPYqEdbxhOc65VTnzEey6sNJOT6m70_YyQq87c7CtPwQ_YJbsIw4XgcDv7B--4o09NTZYYAD4has0RLdZEBEn664o4qStludtAgLLLSjFUrz7f7Ta85oLej1x01I8zpwjZ5ntAHfujK3ASfnw8VcD82vP-gc_7NSd2F9iUjJTtuF7sGKq-_DDsJJdEdkHkNmyVlNECiSaR8rQxpPpmd1MyOXKmwmzX6SmAyEmJCbqG6m6gEcj_Y_746TZbaFxFDESEmhK5p6mwu8uLKssMxllXZCOS4yR1MjFC-LMnNeGFHayhYGwUamrKYuQ1_4EFbrpnaPgYhKZcKyynMl4pjgcZzwmbPa4vyE6gG86dQuzZKKPGTE-C5bEuVcoh5k1MMAXvaiFy3_xk1Cr2Pb9RJqdh4C1iomv0wOJNs9-lrQ_EAeDmCra1y5tNVLnPwILhA4smoAL_rXaGVh60TVrlmgDAtnaWjK8V-P2k7R_yxHyIY4lWOtYtP-vZxyvL8XH578u-hzuH20N5If300-bMIdhGu0jYDbgtX5bOGeIiSa62ex6_8GYmoD3Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+trends+in+the+management+of+minor+salivary+gland+carcinoma&rft.jtitle=Head+%26+neck&rft.au=Poorten%2C+Vincent+Vander&rft.au=Hunt%2C+Jennifer&rft.au=Bradley%2C+Patrick+J&rft.au=Haigentz%2C+Missak&rft.date=2014-03-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1043-3074&rft.eissn=1097-0347&rft.volume=36&rft.issue=3&rft.spage=444&rft_id=info:doi/10.1002%2Fhed.23249&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3221300521
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon